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Abstract
Photoactivatable oligonucleotides are DNA or RNA molecules whose function is temporarily blocked or
"caged" by a chemical moiety that can be activated by light. By using light to turn on activity, high spatial and
temporal control of oligonucleotide function can be attained. We have developed novel techniques to cage
oligonucleotides using light-activatable groups that introduce a strand break upon photolysis. One method of
inhibiting gene expression involves the use of catalytic DNA strands known as DNAzymes, specifically ones
with the ability to cleave RNA. We have demonstrated efficient photomodulation of a biotinylated split
DNAzyme by employing streptavidin to disrupt the active conformation. Light-controlled split DNAzymes
could potentially be a tool for studying gene expression in vitro. Additionally, a novel photochemical approach
for isolating mRNA from single neurons was developed by creating hairpin-bandage hybrids. This design
utilizes a photoactivatable oligonucleotide hairpin that targets the poly(A)+ tails of mRNA. The antisense
strand of the hairpin is linked via a photocleavable spacer to the blocking strand, which is divided into two
parts by a second photocleavable spacer. Experiments in single neurons have confirmed the utility of hairpin-
bandage hybrids for fluorescently monitoring oligonucleotide dissociation in vivo and for isolating of mRNA
from single cells.
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ABSTRACT 
DESIGN AND APPLICATION OF PHOTOACTIVATABLE OLIGONUCLEOTIDES 
Brittani K. Ruble 
Ivan J. Dmochowski 
Photoactivatable oligonucleotides are DNA or RNA molecules whose function is 
temporarily blocked or “caged” by a chemical moiety that can be activated by light.  By 
using light to turn on activity, high spatial and temporal control of oligonucleotide 
function can be attained.  We have developed novel techniques to cage oligonucleotides 
using light-activatable groups that introduce a strand break upon photolysis.  One method 
of inhibiting gene expression involves the use of catalytic DNA strands known as 
DNAzymes, specifically ones with the ability to cleave RNA.  We have demonstrated 
efficient photomodulation of a biotinylated split DNAzyme by employing streptavidin to 
disrupt the active conformation.  Light-controlled split DNAzymes could potentially be a 
tool for studying gene expression in vitro.  Additionally, a novel photochemical approach 
for isolating mRNA from single neurons was developed by creating hairpin-bandage 
hybrids.  This design utilizes a photoactivatable oligonucleotide hairpin that targets the 
poly(A)+ tails of mRNA.  The antisense strand of the hairpin is linked via a 
photocleavable spacer to the blocking strand, which is divided into two parts by a second 
photocleavable spacer.  Experiments in single neurons have confirmed the utility of 
hairpin-bandage hybrids for fluorescently monitoring oligonucleotide dissociation in vivo 
and for isolating of mRNA from single cells.   
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I. Overview of caged compounds 
A “caged” compound can be defined as one whose activity is temporarily blocked 
by a chemical moiety until it undergoes photolysis.  Caged compounds have a chemical 
group that is covalently attached and rapidly cleaved upon irradiation with light.  The 
most famous caged compound is light-activatable ATP, in which the gamma phosphate is 
caged with a 2-nitrobenzyl group or 1-(2-nitro)phenylethyl group.  In the caged state, 
ATP cannot be hydrolyzed by ATP-dependent proteins.  After near-UV irradiation at 340 
nm, the nitrobenzyl group photoisomerizes, causing a bond break with the gamma 
phosphate and restoring ATP function  (Figure 1.1)[1].   
The use of caged compounds can allow reactions to be spatially localized, for 
instance, to single cells, and the time of initiation can also be controlled.  In one example, 
caged ATP was used to study reaction kinetics of contraction and relaxation in muscle 
fibers[2].  This study highlights the key advantages of light-activatable groups, namely 
providing higher spatial and temporal resolution for studying complex biological systems 
than many traditional methods.  To date, several small molecules have been caged for use 
in biological studies; these include Ca2+, fluorophores, neurotransmitters, and other 
nucleotide triphosphates.  Caging groups have also been utilized in a vast array of 
biological studies, such as those examining cell motility and other cellular processes [3].   
II. Examples of caging groups 
The three most commonly used caging groups are nitrobenzyl, coumarin, and 
azobenzene (Figure 1.2).  Since near-UV light is less invasive and orthogonal to most 
biological processes, it is important to find groups that can be uncaged at longer 
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wavelengths.  Nitrobenzyl groups used in caged ATP studies absorb at wavelengths 
below 350 nm, but modifications have been made to improve its uncaging efficiency at 
longer wavelengths.  An improved nitrobenzyl derivative that absorbs at wavelengths 
greater than 350 nm is the 1-(4,5-dimethoxy-2-nitrophenyl)ethyl compound.   
The coumarin caging group is another highly used moiety.  Brominated 7-
hydroxycoumarin-4-ylmethyl esters and carbamates have been used to make two-photon 
caged compounds that have led to the first three-dimensionally resolved maps of neuron 
glutamate sensitivity in intact mouse brain slices[4].  For two-photon uncaging, a 
compound absorbs a pair of photons at IR wavelengths almost simultaneously, as 
opposed to the one UV photon required for other caging moieties.  The longer 
wavelengths required are less affected by scattering, less damaging to cells and biological 
samples, and can penetrate tissue more deeply[5].  However, there are disadvantages to 
two-photon uncaging.  First, it requires pulsed lasers that can be tuned to the wavelengths 
required.  Additionally, this technique is more synthetically challenging, and the 
chemistry involved in synthesizing these compounds is not as well-developed.   
For reversibly controlling function, azobenzene groups have been utilized[6].  At 
visible wavelengths, azobenzene is in the extended trans conformation, but after UV 
irradiation, it adopts the cis conformation.  While the utility of early azobenzene 
derivatives suffered because azobenzene cis  trans isomerizes rapidly at 37 °C, 
requiring continuous UV irradiation to maintain the cis conformation, variants with 
improved thermal stability have been developed recently[7]. 
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More recently, caging techniques have been expanded to develop light-activated 
oligonucleotides for spatiotemporally regulating gene expression to elucidate complex 
biological processes.  By using photolabile moieties that transiently block DNA or RNA 
function, it is possible to control the activity of oligonucleotides in a variety of 
applications.  For instance, controlling when or where proteins are expressed will 
facilitate the study of how they affect cellular development.  Furthermore, the ability to 
isolate total mRNA populations from a single cell at a given point in time will aid in 
elucidating the link between RNA and cell phenotype.   
III. Photoactivatable oligonucleotides 
Caging techniques have greatly expanded over the last twenty years going from 
small molecules to biologically relevant compounds, such as oligonucleotides and 
proteins.  However, caging oligonucleotides is often more challenging than small 
molecules due to their larger size and complexity.  There are currently a few methods to 
incorporate caging groups.  First, if the oligonucleotide is short, the photoactivatable 
group can be made into a phosphoramidite and incorporated during solid-phase synthesis.  
Phosphoramidites, in which a base has been modified with a photocleavable group (such 
as diethylaminocoumarin) at a position on a nucleoside ring[8], have been synthesized, as 
have linkers that can be added between the bases (resulting in strand breaks post-
photolysis)[9].  Photoactivatable groups can also be incorporated after oligonucleotide 
synthesis.  Bifunctional linkers that are reactive with nucleophiles, such as thiols or 
amines, have been successfully added after solid-phase synthesis[10].  Photocleavable 
groups that are reactive to the phosphate backbone of the oligonucleotide have also been 
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utilized[11].  Examples of this type include diazoethane derivatives of coumarin and 
nitrobenzyl groups and 1-(4,5-dimethoxy-2-nitrophenyl)ethyl.   
Even though the term “caging” can be a bit of a misnomer in the case of 
oligonucleotides because caging groups can be incorporated to turn oligonucleotide 
function “off” or “on” post-photolysis, the term “caged” continues to be used because 
their function is controlled by light.  Photoactivatable oligonucleotides have several 
applications, which will be discussed in the sections below.  These include caging 
plasmids and messenger RNA to block transcription or translation, caging atoms required 
for the catalytic activity of nucleic acid enzymes, photomodulating antisense 
oligonucleotides to control oligonucleotide binding to complementary sequences, 
photoregulating oligonucleotides for other uses, and indirectly regulating oligonucleotide 
activity by caging small molecules and cofactors. 
a. Caged plasmids and messenger RNA 
The first example of a caged plasmid used 1-(4,5-dimethoxy-2-
nitrophenyl)diazoethane groups to react with oxygens of the phosphate backbone in a 
GFP plasmid[12].  In this study there were ~270 caging groups per plasmid, and this 
suppressed most transcription of the DNA in HeLa cells.  Unfortunately, the bioactivity 
of the plasmid was not fully restored after uncaging with 365 nm light.  This was likely 
due to the large number of caging groups present, which required a high dose of light for 
photo-deprotection, but this led to cell death.  Additionally, there was some background 
GFP expression because the caging reaction is random, resulting in different plasmid 
structures, with some having no caging groups and others having a large number of them. 
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In another example, Ando et al. utilized 6-bromo-4-diazomethyl-7-
hydroxycoumarin moieties, which form a covalent bond with the phosphate backbone of 
RNA and label ~30 sites per 1 kb of DNA or RNA[13].  Here, a GFP plasmid was caged, 
as was GFP messenger RNA.  The zebrafish was utilized as a model system because of 
its transparency, and after transfection with the GFP plasmid, irradiation with UV light 
resulted in GFP expression, with expression levels increasing with longer irradiation 
times.  They expanded work with this caging group to investigate the role of the lhx2 
gene in zebrafish[14].  While lhx2 is known to be involved in brain and eye development, 
its function had previously been difficult to study because zebrafish embryos would 
become extremely dorsalized with enlarged heads when the gene was overexpressed 
using traditional methods.  This is because overexpression occurs in the whole embryo 
early in development.  By caging lhx2 mRNA, they successfully overexpressed Lhx2 
only in the head at a specific time in development.  By controlling overexpression of 
lhx2, the authors were able to rescue knockdown of another gene, six3, in the head region 
at 11 hours post-fertilization.  This study is a prime example of how useful caged 
oligonucleotides are for studying problems in developmental biology.   
Since the presence of multiple caging groups requires more irradiation to uncage 
than would be necessary for a single caging moiety, more recent strategies have aimed to 
incorporate only one or two caging groups.  Recently, a plasmid with only a single caging 
group was developed[15].  In this design, a DNA primer with a 5′-amine modification was 
synthesized and incorporated into a GFP plasmid a few bases upstream of the 
cytomegalovirus (CMV) promoter via PCR.  After reacting the amine with a 
photocleavable biotin, streptavidin was added to sterically block the promoter region of 
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the plasmid, thus blocking transcription factors from binding.  The caging moiety used 
for this study is the 6-bromo-7-hydroxycoumarin-4-ylmethyl group.  In cell studies, 
enhanced GFP (EGFP) expression increased from 65% of normal levels (i.e. that of non-
caged plasmid) prior to irradiation up to 92% after irradiation.   
b. Light-regulatable catalytic oligonucleotides 
DNAzymes and ribozymes are nucleic acids that are capable of catalyzing 
chemical reactions.  While some ribozymes, such as the hammerhead ribozyme, occur 
naturally, all known DNAzymes have been evolved by in vitro selection.  The first 
example of photoregulating a nucleic acid enzyme incorporated a caged adenosine within 
an RNA cleaving ribozyme[16].  An adenosine with a caged 2′ hydroxyl was synthesized 
as a phosphoramidite to allow it to be incorporated during solid-phase synthesis.  The 2′-
nitrobenzyl cage at this position blocked the ribozyme’s function because the 2′ hydroxyl 
is required for magnesium dependent nucleophilic attack on the phosphodiester linkage in 
RNA.     
Since the first caged ribozyme, other caged nucleic acid enzymes have been 
developed.  Strategies for caging DNAzymes have included blocking their function by 
caging their bases because the catalytic mechanisms of DNAzymes are not fully 
understood.  Two of the most studied DNAzymes are the 8-17 DNAzyme and the 10-23 
DNAzyme, both of which have been caged by site-specifically incorporating 
photoactivatable bases at important positions within the enzyme using phosphoramidite 
chemistry[17].  In both of these studies, DNAzyme function was blocked until uncaging 
with UV irradiation resulted in RNA degradation, which turned gene expression “off.”  In 
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the case of the 8-17 DNAzyme, an adenosine analogue was incorporated at a position in 
the stem loop that is required for activity[17a].  The caged DNAzyme was completely 
inactive, but after irradiation, ~30% of activity was restored.  Lusic et al. developed a 
thymidine phosphoramidite caged with the 6-nitropiperonyloxymethyl (NPOM) group to 
introduce into the catalytic core of a 10-23 DNAzyme[17b].  They discovered that 
disrupting a single hydrogen bond could completely block enzymatic activity if 
strategically placed, and irradiation with 365 nm light could activate the enzyme with 
greater than 50% of the original activity restored.  More recently, the Deiters lab has 
successfully photoregulated DNAzyme function is mammalian cells[18].  Incorporating 
three caged bases into a DNA decoy strand that is complementary to the catalytic loop of 
the DNAzyme prevented the decoy strand from binding the DNAzyme until after 
irradiation with UV light.  After irradiation, the trans acting decoy strand hybridizes to 
the DNAzyme, which prevents RNA digestion.  They also demonstrated that the 
complementary strand could be added before the 5′ binding arm of the DNAzyme rather 
than as a separate strand.  
Additionally, reversible 8-17 and 10-23 DNAzymes with azobenzene have been 
developed.  This approach can be challenging because the oligonucleotide must function 
normally when the azobenzene is in one conformation, but its function must be blocked 
when the azobenzene is in the other conformation.  However, the ability of azobenzene to 
photoisomerize reversibly can be advantageous in some instances since light-activation of 
other caging groups irreversibly removes the photoactivatable moiety.  Because of this, 
reversibly photoregulatable DNAzymes have been developed by replacing important 
bases with a nucleotide that is modified with an azobenzene group[19].  Interestingly, the 
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8-17 DNAzyme displayed higher catalytic activity with azobenzene in the trans form, but 
the 10-23 DNAzyme was more active with the azobenzene in the cis conformation.   
When two azobenzene groups were substituted for nucleotides in the binding arms of an 
8-17 DNAzyme, the catalytic rate of the enzyme was approximately five times higher in 
the trans conformation than in the cis form[19a].  This is a result of the increased stability 
of the enzyme-substrate complex due to the ability of trans-azobenzene to stack within 
the DNA double helix, thereby stabilizing it.  In the case of the 10-23 DNAzyme, a single 
nonconserved nucleotide within the catalytic core of the enzyme was replaced with a 2′-
deoxyuridylate analogue linked to an azobenzene moiety[19b].  When the enzyme-
azobenzene conjugate is in trans form, the activity is decreased by nine-fold compared to 
the wild-type enzyme.  After UV irradiation, when the azobenzene is in the cis 
conformation, the enzyme’s cleavage rate approaches that of the unmodified DNAzyme. 
More recently, a photoregulatable 10-23 DNAzyme nanomachine was created by 
adding complementary hairpin sequences incorporating three or four azobenzenes on 
either side of the DNAzyme’s binding arms[20].  Since the azobenzenes are in the trans 
conformation in visible light, a stable duplex hairpin-like structure forms, and the 
DNAzyme cannot cleave RNA.  However, in UV light, the azobenzenes isomerize, 
causing the duplex to dissociate.  The enzyme is then able to bind and digest its RNA 
target.  Photoregulation of this DNA nanomachine was highly efficient, allowing 
digestion to be turned completely off after UV irradiaton.  
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c. Caged antisense oligonucleotides 
A more recent, widely used caging approach aims to control the activity of 
antisense oligonucleotides.  These are short oligonucleotides comprised of 15-25 
nucleotides that hybridize to an mRNA transcript to cause it to be degraded or prevent 
translation by sterically blocking the ribosome.  For example, when a short DNA strand 
hybridizes to its target mRNA in cells, RNase H is recruited and degrades the mRNA.  
Modified oligonucleotides, such as RNA with 2′ modifications, morpholinos, peptide 
nucleic acids, and phosphorothioate DNA, can bind to an mRNA of interest to prevent 
translation by blocking the ribosome.  The technique most commonly used for antisense 
caging is to block it transiently from hybridizing to its target mRNA.    
As discussed previously with caged plasmids, hybridization of antisense 
oligonucleotides to target mRNA can be prevented by caging the phosphate backbone.  
Ghosn et al. randomly caged the phosphate backbone oxygens of a 20mer DNA using 1-
(4,5-dimethoxy-2-nitrophenyl)ethane[21].  The resulting oligonucleotide was labeled at an 
average of 14-16 sites, and this was sufficient increase disruption of hybridization to a 
complementary molecular beacon from 14% of non-caged control to 80% after 
irradiation with UV light.  To achieve more specific backbone labeling, an iodoacetamide 
derivative of azobenzene has been utilized to cage phosphorothioate DNA[22].  In this 
example, one base per 16mer was caged, and this resulted in a 7 °C decrease in melting 
temperature post-photolysis.   
Photoactivatable modifications within the nucleotides of caged antisense 
oligonucleotides can also be used to control activity.  For example, incorporation of three 
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nitrophenyl-modified thymidine phosphoramidites in a 25-nucleotide DNA strand 
resulted in significant decrease in melting temperature after photocleavage, lowering it by 
21.5 °C[23].  Azobenzene modifications have also been created as phosphoramidites.  By 
incorporating three of these moieties in a 22-nucleotide DNA strand, a three-fold increase 
in RNase H digestion of the target RNA was achieved after UV irradiation[24].  More 
recently, the Deiters group utilized thymidine phosphoramidites in the synthesis of 
phosphorothioate DNA[25].  In this study, incorporation of three or four caged residues 
per 18mer oligonucleotide led to successful gene regulation in cell culture.  This group 
also developed light-activatable morpholino oligonucleotides for controlling EGFP 
expression in cell culture and in live zebrafish embryos[26].  In this study, four morpholino 
monomers caged with the 6-nitropiperonyloxymethyl (NPOM) group were included in a 
25mer sequence.  This design was successful in silencing EGFP expression post-
photolysis in cells, zebrafish, and Xenopus embryos.     
Another method for using antisense oligonucleotides to achieve gene knockdown 
is by caging siRNA to control RNA interference (RNAi)[27].  siRNAs are short RNA 
duplexes comprised of 21-23 base pairs, which can be transfected into cells to achieve 
mRNA degradation.  After transfection, the strands bind to the RNA-induced silencing 
complex (RISC), which removes the sense strand, aids in hybridization of target mRNA 
to the antisense strand, and finally degrades the mRNA.  In one of the earliest examples 
of caged siRNA, the phosphate backbone of a siRNA duplex was labeled with the 1-(4,5-
dimethoxy-2-nitrophenyl)ethyl group; the duplexes were labeled with an average of 1.4 
caging groups to block sterically the siRNA-RISC interaction before photolysis[28].  
When the caged siRNA duplexes were co-transfected with a GFP plasmid into HeLa 
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cells, a two-fold decrease in GFP fluorescence was observed post-photolysis.  
Unfortunately, this technique of caging siRNA did not completely inhibit RNA 
interference.  This is likely because the caging is not site-specific, so some duplexes are 
not modified, allowing them to bind the RISC.  Another potential negative is that 
increasing the number of caging groups (which may be required to ensure all duplexes 
are caged) requires longer irradiation times, and this can lead to phototoxicity.  Longer 
irradiation times also lead to loss of spatial and temporal resolution, which is relevant for 
many biological applications.  Still, this approach was used to label 2′-fluoro modified 
siRNA duplexes with 7.9 caging groups per 21mer sense strand and nine caging groups 
per 21mer antisense strand[29].   The 2′-fluorinated residues were used to increase the 
enzymatic stability of the oligonucleotide in vivo.  This is because 2′-fluoro RNA 
maintains the C3′-endo sugar pucker to preserve the A-form duplex required for RNAi 
activity.  In this example, only ~55% of GFP expression was silenced in cell culture after 
photolysis, but this was an increase from the ~10% silencing observed prior to 
irradiation.  Additionally, the authors demonstrated that the caged 2′-fluoro modified 
siRNA could decrease GFP expression after UV irradiation in zebrafish.   
Another method developed to cage siRNA involves incorporation of a single 
caging moiety at the 5′ terminal phosphate of the antisense strand because it has been 
shown to be necessary for binding to the RISC complex[30].  In one example, a 
nitrophenyl-ethyl (NPE) group was introduced at the 5′-phosphate, reducing siRNA 
activity to 40% and allowing activity to be fully restored after UV irradiation[31].  
Attempting to improve upon this approach, Shah et al. chose to incorporate 1-(4,5-
dimethoxy-2-nitrophenyl) ethyl (DMNPE) groups, but they discovered that this caging 
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group preferentially labels the terminal phosphate groups of oligonucleotides, suggesting 
that those groups were indeed modified in previous studies that sought to cage the 
phosphate backbone[32].  In fact, their work suggests that the commonly employed 
DMNPE group actually reacts poorly with backbone phosphates.  By labeling the 
phosphate groups at the four termini of a siRNA duplex with DMNPE, they achieved up 
to a six-fold decrease in gene expression.  They hypothesize that the incomplete blocking 
they observed before irradiation is due to Dicer developing a tolerance to the 
modifications or to a cellular process that can remove the photocleavable groups.   
To improve the nuclease stability of siRNA, phosphorothioate residues have been 
incorporated while also using the DMNPE caging group[33].  With two phosphorothioate 
linkages per strand at the termini of the duplex, the authors were able to decrease the 
level of RNAi activity prior to uncaging.  In this case, the phosphorothioate groups help 
prevent nucleases from cleaving the DMNPE group from the oligo, keeping the duplex 
blocked until near-UV irradiation. 
Recent work by the Friedman group has focused on fully blocking RNAi activity 
prior to photolysis[34].  With this aim, they developed a new photocleavable moiety, 
cyclo-dodecyl (dimethoxy-2-nitrophenyl)ethyl (CD-DMNPE), which was designed to 
completely block RNAi machinery from interacting with the siRNA.  CD-DMNPE labels 
the terminal phosphates just like the commonly used DMNPE, but this caging group is 
bulkier due to the addition of a carboxyl synthetic handle and amine groups.  The added 
bulk at all four termini should sterically block Dicer or nucleases that could remove the 
caging group.  When modified siRNA duplexes targeting GFP were tested in cell 
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monolayers, they were completely blocked from participating in the RNAi pathway prior 
to irradiation, but after photolysis, native activity was fully restored.   
Additional work with other photocleavable groups, such as biotin, amines, or 
linkage to the sense strand at the 5′-end of the antisense strand, have shown that these 
approaches reduce siRNA activity, but they do not completely abolish it.  This could 
perhaps be because the caging groups only block one of the charges on the phosphate, 
leaving another oxygen unmodified and potentially capable of binding to the RISC[35].  
As demonstrated with other antisense oligonucleotide approaches, caged nucleobases 
have been utilized to photomodulate siRNA activity.  For instance, incorporation of 
caged guanosine or thymidine at positions 9-11 of the antisense strand has led to 
complete photomodulation of activity[36].  Because RNA cleavage occurs opposite the 
tenth and eleventh residues of the antisense strand, this design results in a bulge that 
inhibits RNAi, turning it completely off prior to irradiation.  Activity is fully restored 
post-photolysis.   
d. Photoregulatable aptamers 
Spatiotemporal control of aptamers is another application of light-switchable 
oligonucleotides that has been developed.  Aptamers are short, single-stranded 
oligonucleotides that fold into well-defined shapes upon binding to their target small 
molecules.  Heckel et al. employed caged thymidine nucleobases to photoregulate an 
anti-thrombin aptamer[37].  They chose this 15mer ssDNA because it is one of the most 
extensively studied aptamers to date, and it has a unique, stable G-quartet fold comprised 
of six thymidine and nine guanosine nucleotides.  By incorporating a single NPP-caged 
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thymidine in different locations, it was discovered that thrombin did not interact with any 
of the caged aptamers before irradiation, but binding was almost completely restored 
after uncaging.   
In another study, a coumarin derivative, 6-bromo-4-diazomethyl7-
hydroxycoumarin (Bhc-diazo) was used to cage the phosphate backbone to control the 
previously studied anti-thrombin aptamer[38].  With an average of 6.8 Bhc caging groups 
per 15mer aptamer strand, the caged aptamer still had approximately 14% affinity for 
thrombin; uncaging only restored up to 60% affinity compared to the unmodified 
aptamer.  While the aptamer’s activity was not fully restored post-photolysis, this caging 
group does offer the advantages of synthetic ease of and two-photon uncaging potential.   
In yet another study, a caged aptamer targeting cytohesin was designed[39].  This 
study was interesting in that the authors were able to generate a light-controlled aptamer 
without any prior knowledge of the structure or interactions of the aptamer with its target 
protein.  Cytohesin-1 was chosen as the target because in vitro selection methods aimed 
at discovering an RNA aptamer towards it had already proven successful.  After 
successful aptamer development, it was discovered that a single nucleotide caged with 
either the NPP or NPE groups was sufficient to prevent the aptamer from binding 
cytohesin-1.   
e. Other photoactivatible oligonucleotides  
Early photomodulation of oligonucleotides was developed to assist with 
purification or characterization.  Introduction of a nitrobenzyl moiety during solid-phase 
synthesis allowed for the creation of light-induced strand breaks.  This design allowed for 
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tags, such as fluorophores and biotin, to be removed from the oligonucleotide by 
photolysis when they are no longer necessary.  The photocleavable groups can also be 
incorporated as protecting groups during solid-phase synthesis[40].  Rather than using the 
standard treatment of ammonium hydroxide to cleave oligonucleotides from solid support 
and remove the protecting groups, irradiation can be used.  In 1996, Olejnik et al. 
developed a photocleavable biotin (PCB) phosphoramidite to aid in purification and 
phosphorylation of oligonucleotides[41].  The PCB was incorporated on the 5′-terminal 
phosphate during solid-phase synthesis, allowing the full-length oligonucleotide to be 
isolated via incubation with immobilized streptavidin.  To attain the pure desired product, 
the oligonucleotide was then irradiated with 300-350 nm light, which cleaved the PCB 
moiety.  In another study, a photocleavable spacer comprised of a 2-nitrobenzyl group 
was introduced to connect a DNA strand to a fluorescein at the 5′-end[42].  By also 
incorporating a 3′-biotin, the oligonucleotide was first immobilized on a streptavidin-
coated glass surface.  After irradiating the sample with UV light and washing thoroughly, 
the change in fluorescence before and after photolysis could be measured.  This study 
found an almost 80% decrease in fluorescence after photolysis and laid the groundwork 
for utilizing a dye-labeled photocleavable nucleotide for DNA sequencing[43]. 
Strand breaks such as these have also been utilized to identify single base 
mismatches.  Since single nucleotide polymorphisms (SNPs) may be responsible for 
some types of genetic diseases, a rapid and inexpensive detection method would be 
highly useful.  In one technique, a fluorescence detection assay was developed to identify 
single-base mismatches by exploiting the lower melting temperatures of strands with 
mismatches after photolysis[44].  A DNA strand with a centrally-located photocleavable 
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group (5′-o-nitrophenyl thymidine) and a Disperse Red 1 detection tag at the 5′-end was 
immobilized on agarose so that the target strand did not require modification in any way.  
After hybridization of the target strands and UV irradiation, the tag remained bound to 
the solid support in the case of a fully matched strand, but the red tag was released into 
solution in the mismatched case.  This assay was effective in detecting even a single 
mismatch after a two hour hybridization and subsequent ten minute irradiation time. 
Recently, caged oligonucleotides have been utilized in the development of 
nanodevices.  For example, an azobenzene-modified reversible DNA nanotweezer has 
been developed[45].  When the azobenzene groups were in the trans configuration, the 
tweezers were closed.  Upon UV irradiation, the azobenzene groups isomerized, opening 
the tweezers.  DNA nanoscissors have also been brought under the control of light[46].  
Work by Tsai et al. combined a nanoparticle core with a monolayer of hydrazone-
modified triplex-forming oligonucleotides, which are able to capture and cleave their 
target DNA duplex after irradiation at 460 nm.    
Other caged oligonucleotides have been utilized to control PCR product 
generation.  The Deiters lab incorporated caged thymidine residues into DNA primers, 
disrupting DNA hybridization until after photoactivation[47].  This allowed them to 
temporally control activation of the PCR reaction.  Additional work by Tanaka et al. also 
controlled PCR with light via incorporation of a caged thymidine into a PCR primer[48].  
The caged nucleotide was incorporated site-specifically to block DNA polymerase under 
PCR conditions, so the elongation products of the PCR cycles before irradiation were 
terminated at the caged residue.  After UV irradiation to remove the NPP caging groups, 
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sticky ends were created at the end of the PCR products.  These products were then 
ligated into an expression plasmid following digestion with restriction enzymes. 
Additionally, photomodulation of nucleic acid folding has been achieved.  Better 
understanding of DNA and RNA folding can be useful for discovering important tertiary 
contacts and for differentiating between local and global structure formation.  Controlling 
this folding with light may lead to real-time monitoring of folding kinetics.  As a proof-
of-concept study, the Silverman lab incorporated 2-nitrophenyl ethyl (NPE) caged RNA 
nucleotides to study the folding of Tetrahymena group I intron RNA, whose tertiary 
structure is already well-defined[49].  Each of the four RNA nucleotides was caged, and 
one caged base per RNA strand was incorporated strategically based upon the molecular 
X-ray crystal structure.  The caging groups were successful in disrupting global folding 
of the RNA, and folding was restored upon photolysis.  The Heckel group opted to probe 
the G-quadruplex formation of a common sequence used for studying telomeric DNA[50].  
Different dG nucleotides were replaced with NPP-caged ones, and it was discovered that 
substitution of just one residue in the core of the sequence was enough to prevent G-
quadruplex formation.   
f. Indirectly photomodulated oligonucleotides 
Toyocamycin, a small molecule inhibitor of a self-cleaving ribozyme, was caged 
to control expression of a luciferase mRNA transcript[51].  In this design, a self-cleaving 
ribozyme sequence was cloned into the 5′-UTR of a luciferase mRNA to test the efficacy 
of the caged small molecule.  In the presence of toyocamycin, the correct folding of the 
ribozyme is inhibited.  When the caged toyocamycin was co-transfected with the plasmid 
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in cell culture, the self-cleaving ribozyme was able to cleave itself prior to irradiation, 
resulting in degradation of the transcript and no luciferase expression.  After irradiation, 
toyocamycin was able to inhibit the ribozyme’s function, so the transcript was intact, 
allowing for luciferase expression.   
Another example is the light-activation of a riboswitch regulatory cofactor.  
Riboswitches are non-coding RNAs that are usually located in the 5′-UTR of bacterial 
genes.  When a riboswitch binds to its cofactor, usually a metabolite, it undergoes a 
conformational change, which results in control of gene expression.  Recently, 
glucosamine-6-phosphate (GlcN6P), the cofactor for the glucosamine-6-phosphate 
synthetase (glmS) riboswitch, was caged[52].  When the glmS riboswitch was cloned into 
the 3′-UTR of an EGFP plasmid, the riboswitch retained its self-cleavage activity in the 
presence of caged GlcN6P.  However, after irradiation, the uncaged cofactor reduced the 
amount of EGFP translated.   
Photoregulatable cellular delivery is yet another example of indirect caging of 
oligonucleotides.  An example of this is the modification of cationic gold nanoparticles 
with a nitrobenzyl group modification[53].  Prior to irradiation, DNA associates with 
positively-charged nanoparticles with photoactive groups present.  After UV irradiation, 
the nitrobenzyl linkage is cleaved, leaving a negatively charged carboxylate group on the 
nanoparticle.  When this occurs, the negatively changed backbone of DNA is released 
from the nanoparticle, resulting in gene expression being turned “on.” 
In another report, Young et al. used spiropyran, as their light-sensitive small 
molecule[54].  This chromophore is able to undergo rapid conformational changes to 
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isomers of different colors.  More specifically, in visible light conditions, spiropyran is 
colorless; after irradiation with UV light, it switches to its purple merocyanine form.   
Utilizing in vitro selection methods, an RNA aptamer capable of binding to one form of 
spiropyran was engineered.  Upon binding spiropyran, the conformation of the RNA can 
be reversibly switched by applying UV light, resulting in release of the aptamer.     
 As these diverse examples and new advances (such as light-controlled molecular 
beacons[55] and microRNA inhibitors[56]) demonstrate, there are multitudes of uses for 
caged oligonucleotides.  However, there are also a number of improvements that are still 
necessary.  Next, the contribution our lab has made in advancing strategies for 
photomodulating oligonucleotides will be discussed.   
IV. Improving photoactivatable oligonucleotides 
 In some of the first examples of caging oligonucleotides, large excesses of caging 
groups were used to non-specifically label many sites on plasmids and mRNA.  In 
addition to increasing the cost of synthesis, multiple caging groups are inefficient to 
uncage and require longer irradiation times.  Our group aims to improve upon the 
existing methods by developing new designs that only require one or two caging 
moieties.  We also incorporate them site-specifically to control oligonucleotide function.  
Furthermore, we have introduced fluorescent reporters to verify photolysis. 
 One of our lab’s earliest approaches involved the synthesis of a DNA primer 
strand with an adjacent photocleavable fluorophore-quencher pair which prevented 
extension of the primer by DNA polymerase[57].  In this design, the quencher was 
removed after photolysis (which was confirmed by an increase in fluorescence) and the 
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primer was extended (Figure 1.3).  In additional work by our lab, Dr. XinJing Tang 
developed a novel method for controlling oligonucleotide hybridization[58].  Using a 
single photocleavable linker to join an antisense DNA to its complementary strand, he 
was able to block the DNA from binding to its normal RNA target.  The photocleavable 
linker includes a malemide for reaction with thiols and an NHS ester for reaction with 
amines.  The DNA and blocking strands were synthesized with amine and thiol 
modifications to facilitate reaction with the linker after synthesis (Figure 1.4).  Before 
photolysis, the complementary strand has a high melting temperature because it is 
covalently attached to the DNA, but after UV irradiation, the strand is no longer attached 
and can dissociate.  This allows the DNA to bind its target RNA, which is significantly 
longer than the complementary strand.  These photoactivatable DNA hairpins were then 
used to regulate RNase H-mediated RNA digestion in cells[59].  This work was further 
extended to another antisense oligonucleotide, negatively charged peptide nucleic acid, to 
photoregulate the expression of bozozok and chordin genes in zebrafish embryos[60].  The 
DNA hairpin design necessitates a balance between a high melting temperature between 
the DNA and blocking strand before photolysis and a low melting temperature afterwards 
so that the DNA will hybridize preferentially to the RNA and not to the blocking strand.  
Therefore, optimization was required to determine the length and position of the blocking 
strand. 
While DNA hairpins are useful for turning gene expression “off” after photolysis, 
Dr. Julia Richards, a previous graduate student in our lab, thought it would be equally 
useful to turn gene expression “on.”   Based on this premise, she sought to develop RNA 
bandages which are comprised of two 2′-O-methyl (2′-OMe) RNA strands joined by the 
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aforementioned photocleavable linker[61].  In this design (Figure 1.5), 2′-OMe RNA was 
employed because previous work studying structural modifications to antisense 
oligonucleotides that would improve mRNA binding affinity and specificity discovered 
that this modification of the RNA ribose ring improves both nuclease resistance and 
mRNA hybridization[62].  The design of RNA bandages enabled them to bind their 
mRNA target at the start codon and Kozak sequence in the 5′-UTR to block translation 
until uncaging.  Because the timing and location of protein expression in cells are 
important, controlling these factors could shed light on the function of genes of interest.  
In this design, the melting temperatures of the two short, tandem oligonucleotides are 
significantly lowered after photolysis when compared to the caged oligonucleotide.  This 
decreased affinity for the target allows them to melt off the mRNA, allowing the 
ribosome to bind and translate the mRNA.  While the best bandage design resulted in a 
three-fold increase in translation after photolysis, there were drawbacks to this design.  
During bandage optimization, it was discovered that there was not a simple correlation 
between the change in melting temperature and a bandage’s ability to block translation.  
This could make it difficult to design bandages for sequences with poorly understood 
secondary structures.    
Additional work by Dr. Richards centered around photoregulating the 10-23 
DNAzyme[63].  While the 10-23 DNAzyme had been site-specifically regulated 
previously using caged bases, our lab aimed to turn its activity on and off using a 
photocleavable spacer.  The advantage of this approach is that the photocleavable spacer 
is commercially available as a phosphoramidite, eliminating the need to perform a 
lengthy synthesis of caging an individual nucleotide phosphoramidite.  This also allows 
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for the photocleavable group to be incorporated at any desired position within the 
oligonucleotide.  In order to turn the DNAzyme’s activity “off,” two photocleavable 
spacers were incorporated within the DNAzyme, one in a binding arm and one within the 
catalytic core (Figure 1.6).  To create a DNAzyme that can be turned “on,” a circular 
DNAzyme linked to a complementary strand with two photocleavable spacers was made.  
After UV irradiation, the blocking strand melts off the DNAzyme, leaving the enzyme 
free to bind and cleave its target RNA.  These strategies should facilitate the development 
of DNAzymes for numerous uses in biotechnology. 
V. Research Aims 
Work presented in this dissertation demonstrates novel ways of caging 
oligonucleotides.  In chapter two, a new method for photoregulating a 10-23 DNAzyme 
and characterization of its catalytic loop are discussed[64].  The third chapter presents a 
new design for improving caged hairpins with the addition of a second photocleavable 
linker and a FRET pair (to monitor dissociation post-photolysis) along with results from 
its application in neurobiology.  Finally, a new technique for caging siRNA by 
enzymatically circularizing it is proposed, and the initial synthesis, purification, and 
ligation schemes are presented.    
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Figure 1.1  Caged ATP structure and photolysis. 
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Figure 1.2  Structures of caging moieties commonly used for oligonucleotides.  Wavy 
lines indicate the point at which the oligonucleotide is attached.  A) Nitrobenzyl group 
and common derivatives, B) Coumarin group with derivatives, and C) Azobenzene. 
 
 
 
 
 
 
Figure 1.3  A)  Strategy for photoregulation of primer extension using Klenow fragment 
(KF).  Adjacent cytidines
dabsyl (red) prevent DNA polymerase from extending 
removes dabsyl, which allows
green.  B) Structure and photolysis
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Figure 1.4  A) Scheme for the design of light
oligonucleotide (red) is blocked from binding mRNA (purple
(black) joined by a photocleavable linker (green
complementary blocking strand can be varied to optimize hybridization.  After 
photolysis, the antisense oligonucleotide
B) Structure of the heterobifunctional linker
This figure was adapted from X. Tang et al. Angew. C
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Figure 1.5  General strategy for making caged RNA bandages.  Bandages comprised of 
two short 2′-OMe RNA strands complementary to an mRNA target are linked via a 
photocleavable linker.  Before irradiation, the bandages blocked translation.  After 
photolysis, the strands melt off, restoring translation.    
This figure was adapted from J. Richards et al. Bioorg. Med. Chem. Lett., 2008, 18, 
6255-6258. 
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Figure 1.6  Design for photoregulating the 10-23 DNAzyme.  A) Two photocleavable 
groups (gray box) placed in the binding arm and catalytic core of a DNAzyme prevent 
the enzyme from cleaving RNA after UV irradiation.  B)  A circular DNAzyme linked to 
a complementary strand via two photocleavable spacers cannot cleave its RNA substrate 
until activity is restored with UV light. 
This figure was adapted from J. Richards et al. ChemBioChem., 2010, 11, 320-324.   
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Mismatch discrimination and efficient photomodulation of split 
10-23 DNAymes 
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I. Introduction 
Since Breaker and Joyce’s report of an RNA-cleaving DNAzyme in 1994[1], 
DNAzymes have become important biochemical tools[2] and have been utilized for 
applications as diverse as RNA ligation[1] and Diels-Alder reaction catalysis[3].  
Additionally, recent advances have succeeded at creating DNAzymes that are promising 
biosensors[4] and potential therapeutic agents for gene suppression[5].  Furthermore, by 
cloning the 10-23 DNAzyme into a plasmid, progress has been made in creating 
DNAzymes that do not require exogenous delivery[6].   
One of the most widely studied DNAzymes is the 10-23 DNAzyme, which can 
cleave RNA at a junction between purine and pyramidine bases, preferentially A–U[7].  
The 10-23 DNAzyme structural motif consists of a 15-nucleotide (nt) catalytic loop 
flanked by two 6-12-nt binding arms that are complementary to the RNA target (Figure 
2.1).  Enzyme activity is dependent on divalent metal ion binding to the catalytic loop[1, 
8]
.  The catalytic loop has been studied by deletion[9] and mutation[10] of residues, and by 
substitution of the backbone phosphates with phosphorothioates[11].  However, the 
structure of the loop and its catalytic mechanism require further characterization.  The 
existing crystal structures are not believed to represent the active conformation of the 
loop, which is likely very flexible[12].  Our lab’s recent discovery that the 10-23 
DNAzyme can work as two separate ‘a’ and ‘b’ strands (Figure 2.1) exemplifies this 
flexibility[13].  Here, we sought to expand our understanding of the structural 
requirements of the split 10-23 DNAzyme and investigate its potential for mismatch 
discrimination and photoregulation.    
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The ability to function in two parts is not unique to the 10-23 DNAzyme, as it has 
also been demonstrated with peroxidase-like DNA enzyme[14], DNAzyme E6[15], and 
deoxyribozyme ligase[16].  Furthermore, multi-component nucleic acid enzymes 
(MNAzymes), which become catalytically active when an assembly facilitator is added to 
the partial enzymes, have been developed[17].  Additionally,  two-component DNAzymes 
consisting of 2′-O-methylribonucleotide effectors and 10-23 DNAzymes with shortened 
3′ binding domains have been engineered[18].  These notable examples motivated us to 
investigate further the structural requirements of the 10-23 DNAzyme.   
We chose a DNAzyme with binding arms that target VEGFR2 RNA, which was 
shown previously by Zhang et al. to achieve gene knockdown in cell culture and mice[5a].  
We determined that this full-length DNAzyme exhibits activity even at low 
concentrations of the requisite divalent metal ion.  This favors its use for in vivo studies, 
and also provides a useful platform for designing split DNAzymes.  We explored the 10-
23 DNAzyme’s functionality as separate strands by dividing the enzyme between 
different residues of the catalytic loop to generate fourteen split DNAzymes, Dz1-Dz14 
(Figure 2.1).  The split DNAzymes cleaved RNA with efficiencies that depended on 
where the loop was divided.  Split DNAzymes divided at the middle of the catalytic loop 
(Dz7, Dz8) showed activity comparable to the full-length enzyme (Dz0).  Because of the 
short length of the binding arms (9-nt), the split enzymes were more sensitive than Dz0 to 
single base mismatches with the target RNA.  Much higher metal ion concentrations were 
required to maintain activity than observed with the full-length DNAzyme.  
After determining the best cleaving half enzymes, we aimed to design a 
photoregulatable DNAzyme that could be turned “on” upon irradiation.  RNA-cleaving 
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DNAzymes, such as the 10-23 DNAzyme, have been demonstrated to be promising gene 
silencing agents[5a, 19], motivating the development of light-controlled DNAzymes for 
possible biological applications[5b].  In a pioneering example[20], Lusic et al. disrupted 
DNAzyme function by incorporating photoresponsive bases within the 8-17 and 10-23 
DNAzymes using phosphoramidite chemistry.  When the DNAzymes were photolyzed, 
the caging groups were removed, which activated enzyme activity and turned gene 
expression “off”.  Additionally, DNAzymes that can be activated and deactivated with 
light in mammalian cells have been developed[19].  To achieve this, caged thymidine 
residues were site-specifically incorporated within the DNAzyme or a DNA decoy strand.  
In order to turn DNAzyme function from “on” to “off,” caged DNA decoys or hairpin 
DNAzymes with thymidines in positions that prevent hairpin formation prior to 
irradiation were employed.  To activate the DNAzyme, caged residues were incorporated 
within the catalytic loop to prevent the DNAzyme from cleaving RNA or within the 
binding arms to prevent hybridization to the target.   
While several techniques for turning DNAzyme function from “on” to “off” have 
been developed[13, 19], there are fewer that allow DNAzyme function to be turned “on”[21] 
using a single photoactive group[21a, 21c], as we have shown can achieve very efficient 
photomodulation of oligonucleotide function[22].  Ting et al. pioneered the design of a 
photoregulatable DNAzyme with a single caging moiety, however the 280 nm light 
required to activate this enzyme is undesirable for most biological studies[21c].  The 
photoswitchable DNAzyme designed by Keiper et al. incorporated a single azobenzene-
modified nucleotide in the catalytic loop[21a].  We previously discovered that the activity 
of the full-length 10-23 DNAzyme can be turned from “off” to “on” upon 365 nm 
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irradiation by attaching a complementary strand via two photocleavable linkers and 
circularizing the conjugate using Circligase[13].  Similar approaches employing a single 
photocleavable linker joining an oligonucleotide to a complementary blocking strand 
have been designed[22c, 23].  In our previous approach, the DNAzyme was no longer 
covalently bound to the blocking strand after near-UV irradiation, allowing it to cleave its 
RNA target.  However, native activity was not fully restored post-photolysis, based on 
lingering hybridization of the DNAzyme to the sense strand.  This motivated the search 
for alternate photoregulation approaches.   Previous work by Stojanovic et al. showed 
that incorporating a biotinylated dT in deoxyribozyme E could block activity in the 
presence of streptavidin[24].  Similarly, a biotinylated caging agent was used to recruit 
streptavidin to block transcription factors from binding to a promoter sequence of an 
expression plasmid[25].  In our study, efficient photoregulation of a biotinylated split 10-
23 DNAzyme was achieved by employing streptavidin to disrupt the active conformation.  
Unlike in previous strategies, the DNAzyme with photocleavable biotin can be 
constructed entirely from commercially available reagents in high yield using solid-phase 
DNA synthesis.   
II. Experimental procedures 
a. RNA cleavage by DNAzymes 
Single turnover reactions (total volume 24 µL) were performed at 37 °C with 50-
fold excess of DNAzyme to RNA substrate.  DNAzyme (4.2 µM) and 0.083 µM P-32 
labeled 28-nt RNA substrate (5′-GCGCGAGGUGCAGGAUGGAGAGCAAGGC-3′, A–
U cleavage site highlighted in bold) were reacted in standard buffer, defined here as 10 
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mM Tris buffer (pH 7.5) with 10 mM MgCl2 and 83 mM NaCl.  Oligonucleotides were 
obtained from Integrated DNA Technologies.  Aliquots (4 µL) were removed after one 
hour, at which point the reaction was quenched with 6 µL RNA loading buffer II 
(Ambion).  The aliquots were analyzed by polyacrylamide gel electrophoresis (PAGE) 
using a 7 M urea, 20% polyacrylamide gel at 300 V for 40 minutes.  Gels of RNA 
digestion were imaged using an Amersham Biosciences Storm 860 phosphorimager.  
Gels were subsequently analyzed using TotalLab Software (Nonlinear Dynamics) to 
detect the band intensities and correct for background using the rubber band subtraction 
function.  Finally, the ratio of intensities of the uncleaved and cleaved RNA bands was 
calculated.  
b. Thermal denaturation of DNAzyme-RNA hybrids   
Thermal denaturation studies were conducted in standard buffer with a 19-nt 
RNA sense strand (5′-AGGUGCAGGAUGGAGAGCA-3′) (1 µM) incorporating a non-
cleavable 2′-O-methylated (2′-OMe) adenosine (highlighted in bold) at the typical 
scission site.  To hybridize the split DNAzyme (1 µM) to this RNA target, solutions were 
heated to 95 °C for five minutes in a water bath and then allowed to cool to room 
temperature.  Melting studies were conducted on a Beckman Coulter DU800 UV-Vis 
spectrophotometer equipped with a programmable Peltier temperature controller.  
Samples were monitored at 260 nm while being heated or cooled at a rate of 1.0 °C min-1, 
with a one minute hold per degree Celsius.  Melting temperatures were determined from 
the peak of the first derivative plot of A260 versus temperature.   
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c. Circular dichroism spectroscopy of DNAzyme-RNA hybrids 
Circular dichroism (CD) spectroscopy was performed using an Applied 
Photophysics Chirascan instrument.  Samples of 2 µM DNAzyme and 2 µM 19-nt non-
cleavable 2′-OMe RNA target were prepared in standard buffer.  Samples were pre-
annealed by heating to 95 °C for five minutes and cooling slowly to room temperature. 
d. Photoactivation of biotinylated split DNAzymes   
The RNA cleavage assay (total volume 24 µL) was performed in standard buffer 
with equimolar DNAzyme halves Dz7a or Dz8a (4.2 µM) and photocleavable 5′-
biotinylated Dz8b.  The solution was irradiated by UV transilluminator (9 mWcm-2 at 365 
nm) for 20 minutes.  Non-irradiated control reactions were also prepared.  Next, 
streptavidin (100 pmol, equimolar with DNAzyme) was incubated in the reaction mixture 
at 37 °C for 30 minutes, P-32 labeled RNA substrate (0.083 µM) was added, and the 
reaction was allowed to proceed for one hour at 37 °C.  Aliquots (4 µL) were analyzed by 
PAGE as described above. 
III. Results and discussion 
a. Split DNAzyme characterization 
The full-length 10-23 DNAzyme in this work (Dz0) has 18 bases complementary 
to the target RNA, while the split DNAzymes have separate binding arm regions that are 
each just nine nucleotides long.  Thermal denaturation experiments (Figure 2.2) 
confirmed that the split DNAzymes produce lower melting temperatures, relative to Dz0, 
when hybridized to a 19-nt non-cleavable RNA target.  Melting temperatures (Tm) for 
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Dz1-Dz14 ranged from 54 °C to 57 °C, compared to 65 °C for Dz0.  We also performed 
circular dichroism (CD) spectroscopy of Dz8, Dz0 and DNAzyme halves Dz8a or Dz8b, 
hybridized to the same non-cleavable RNA target (Figure 2.3).  CD spectra of the 
DNAzyme-RNA hybrids (Figure 2.3) agreed with the previously published CD spectrum 
of Dz0 by Cieslak et al[26].  The asymmetric peak at 270 nm, the negative effect at 244 
nm, and the peak at 223 nm are characteristic of DNAzyme-RNA hybrids[26], and are also 
consistent with our previous characterization of Dz0[13]. 
b. Activity of split DNAzymes 
We tested mixtures of split DNAzymes lacking the internal phosphate group, 
where the DNA was divided into hydroxyl-terminated ‘a’ and ‘b’ strands at every residue 
of the catalytic core (Figure 2.1C).  The reaction was initiated upon addition of RNA to 
the DNA ‘a’ and ‘b’ strands, without pre-incubation.  The large excess of DNAzyme was 
used to find reaction conditions with even low-level activity, in order to guide enzyme 
optimization. 
Dividing the catalytic loop between nucleotides 7 and 8 (Dz7), 8 and 9 (Dz8), 11 
and 12 (Dz11), and 12 and 13 (Dz12) produced very functional split DNAzymes.  Dz11 
and Dz12 cleaved greater than 25% of the RNA target after one hour incubation, whereas 
the most efficient split enzymes (Dz7, Dz8) cleaved approximately 50% (Figure 2.4).  
Under the same conditions, the full-length enzyme (Dz0) cleaved 75% of the RNA target.  
Split DNAzymes divided between nucleotides 6 and 7 (Dz6), 9 and 10 (Dz9), 13 and 14 
(Dz13), and 14 and 15 (Dz14) cleaved 4-10% of the RNA.  Dividing the DNAzyme at 
other loop positions did not produce measurable activity. 
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c. Metal ion requirements of split DNAzymes 
To investigate further the functionality of the split catalytic loop, we tested the 
activity of Dz0 and Dz8 in the presence of various divalent metal ions.  While the 10-23 
DNAzyme was originally discovered to be Mg2+ dependent, studies have shown a T8 
mutant has comparable activity with Ca2+[9].  We found that Dz0 and Dz8 were able to 
cleave the RNA target in the presence of Mg2+, Mn2+, and Ca2+, with Dz8 somewhat less 
active in each case (Figure 2.5).  Furthermore, the split enzymes were found to have 
similar melting temperatures with each of these metal ions (Figure 2.2).  We also tested 
DNAzyme activity with Na+ ion to rule out any contribution of this monovalent cation to 
RNA cleavage.  Finally, Zn2+ was found to elicit no activity in Dz0 or Dz8, as has been 
seen previously with the 10-23 DNAzyme[8].  Next, we varied the concentration of Mg2+ 
ion to determine the optimal RNA cleavage conditions.  Reactions with Dz0 resulted in 
significant cleavage with Mg2+ ion concentrations as low as 0.01 mM.  Neither Dz0 nor 
Dz8 were active when no Mg2+ was added to the buffer (Figure 2.5).  However, Dz8 
showed modest activity at 3 mM Mg2+ and showed high activity only at concentrations 
above 5 mM Mg2+ (Figure 2.6).  The requirement for much higher magnesium ion 
concentration (in the background of high ionic strength standard buffer) suggests that the 
split DNAzymes have lower affinity for Mg2+ ions that are critical for catalytic activity.   
The finding that the full-length DNAzyme is still active at 0.01 mM Mg2+ was 
initially surprising, as Cieslak et al. previously discovered that the 10-23 DNAzyme 
targeting β3 Integrin mRNA is only active at Mg2+ concentrations at or above 0.5 mM[26].  
Concerns that residual Mg2+  ions may remain after the T4 polynucleotide kinase reaction 
to P-32 label the RNA substrate led us to test the ability of the DNAzyme to cleave a 
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non-labeled RNA substrate (Figure 2.7).  This experiment confirmed our previous 
findings, as the full-length enzyme was still able to cleave the RNA substrate.  While this 
activity at low Mg2+  concentration was unexpected, it is noteworthy that successful 
cellular experiments by Zhang et al. were performed with the same DNAzyme employed 
in our work[5a].  Since this DNAzyme was able to function at intracellular Mg2+ 
concentrations, which are approximately 0.5 mM for free Mg2+, it is conceivable that it 
could exhibit catalytic activity at the low concentration demonstrated here.  The 
difference in Mg2+ requirements for these different 10-23 DNAzymes may be due to 
differences in binding arm sequences.  This hypothesis is supported by a previous study 
which discovered that two DNAzymes that both target telomerase mRNA have large 
differences in their optimal Mg2+ concentrations[27].  One enzyme is most efficient at 1 
mM and the other at 20 mM.  Upon further investigation, the enzymes showed little 
difference in Mg2+ requirements once the DNAzymes had hybridized to their targets.   
d. Split DNAzyme mismatch detection 
To assess mismatch discrimination, we tested both the full-length DNAzyme 
(Dz0) and the split DNAzyme with the highest activity (Dz8) by introducing one 
noncomplementary base at different positions within the binding arms of both enzymes 
(Table 2.1).  Gel electrophoresis showed that the intact 10-23 DNAzymes were able to 
cleave the 28-nt RNA target efficiently in all cases, with the original, full-length 
DNAzyme sequence (Dz0, Table 2.1) yielding very similar cleavage efficiencies to the 
seven full-length mismatch sequences (m1-m7, Table 2.1).  Yields of RNA cleavage 
ranged from 70-80% for most sequences tested, but decreased to 50-60% when the 
mismatch was closest to the catalytic loop, in m3 and m4 (Table 2.1, Figure 2.8A).  
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By comparison, considerably higher mismatch discrimination was observed for 
the split DNAzymes.  The seven split DNAzymes with mismatch sequences (m1-m7) 
demonstrated significantly less RNA cleavage relative to the comparable full-length 
DNAzymes in all cases, with greater than 20% cleavage observed only for split 
DNAzymes m1, m6, and m7  (Table 2.1, Figure 2.8B).  
e. Photoactivatable split DNAzyme 
Having determined that Dz7 and Dz8 give the highest activity among the split 
DNAzymes, we hypothesized that split DNAzyme activity could be inhibited by placing 
a biotin moiety near the center of the catalytic loop (Figure 2.9A).  We incorporated a 
photocleavable biotin at the 5′ end of Dz8b and performed the standard cleavage reaction 
by adding Dz8a and the 28-nt RNA target.  A small amount of DNAzyme activity was 
retained when biotinylated Dz8b was paired with Dz8a (Figure 2.10).  However, when 
the biotinylated split DNAzymes (Dz7a + Dz8b or Dz8a + Dz8b) were incubated with 
streptavidin, all catalytic activity was lost (Figure 2.9C).  We tested Dz7a because our 
previous study demonstrated that substituting the thymine in position 8 in the catalytic 
loop with a photocleavable spacer resulted in a highly active enzyme upon photolysis[13].   
Activity was restored by irradiating at 365 nm, which cleaved the biotin moiety 
and allowed separation from the streptavidin blocking agent.  Interestingly, DNAzyme 
activity was restored to 60% RNA cleavage for Dz7a and 39% RNA cleavage for Dz8a 
upon photolysis (Figure 2.9C).  This increased activity with Dz7a and Dz8b has been 
seen previously when residues within the full-length 10-23 DNAzyme were replaced with 
a photocleavable spacer and then irradiated[13].  Notably, the 60% activity observed post-
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photolysis for Dz7a + Dz8b equates to complete restoration of native activity for this split 
DNAzyme.  In this example, we succeeded in turning the DNAzyme from completely 
“off” (< 1 % activity) to completely “on”, with no apparent interference from the biotin-
streptavidin pair.  The recovery of activity when Dz8b was no longer covalently linked to 
biotin-streptavidin suggests a lack of non-specific binding of streptavidin to the 
oligonucleotides or metal ions in solution.  An added benefit of regulating a split 
DNAzyme rather than Dz0 is that the split enzymes retain their sensitivity to single base 
mismatches post-photolysis (Figure 2.11).   
IV. Conclusions 
In conclusion, we have demonstrated that the best split DNAzymes (Dz7, Dz8) 
are nearly as active as the full-length DNAzyme (Dz0) (Figure 2.4).  Our discovery that 
the most active split enzymes are those divided after the 7th or 8th nucleotide is consistent 
with earlier observations that the full-length DNAzyme best tolerates mutations and 
deletions closest to the center of the catalytic core[10].  This flexibility of the catalytic loop 
is not unique to the 10-23 DNAzyme: studies of the 8-17 DNAzyme have demonstrated 
that its catalytic domain can be modified to contain only guanosine and cytodine residues 
while still retaining detectable enzymatic activity[28], and an extensive mutational analysis 
of its catalytic core has shown  the ability to retain activity[29].  Additionally, we have 
established that the full-length 10-23 DNAzyme targeting VEGFR2 mRNA is capable of 
retaining enzymatic activity at Mg2+ concentrations as low as 0.01 mM, providing support 
for the use of DNAzymes in cellular studies.  We further demonstrated that the recently 
discovered ability of DNAzymes to function as split enzymes imparts greater selectivity 
towards the RNA target.  Tuning the affinity of the short ‘a’ and ‘b’ strands provides a 
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route for achieving even higher single-base mismatch selectivity.  In addition to our 
experiments with the split 10-23 DNAzyme, Kolpashchikov developed a split 
peroxidase-like DNAzyme to be used for colorimetric detection of SNPs[15a].  Finally, 
because photochemical approaches for modulating gene expression have many potential 
uses in biological systems[30], we were interested in exploring the utility of 
photocleavable biotin.  Our approach incorporates a photocleavable biotin moiety at a 
position within the DNAzyme that can tolerate substitution.  In the case of the Dz7a + 
Dz8b split DNAzyme, we showed complete blockage by streptavidin and then complete 
restoration of activity upon biotin photo-release.  The ability of the 10-23 DNAzyme to 
function in two parts creates flexibility, with new avenues for controlling its function.   
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Figure 2.1  A) General scheme for the formation of active DNAzyme from two separate 
DNA strands. B) Sequences of RNA target (red), full-length DNAzyme (Dz0, with sticky 
arms in black and catalytic loop in blue).  C) Sequences of Dz0 and split DNAzymes 
(Dz1-Dz14), with loop residues indicated in blue. 
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Figure 2.2  Melting temperature data for DNAzymes hybridized with 19-nt RNA target 
with a 2′-OMe adenosine at the cleavage site.  Melting temperature studies were 
performed in standard DNAzyme buffer (10 mM Tris buffer, pH 7.5, with 10 mM MgCl2 
and 83 mM NaCl).  For studies testing different metal ions, the 10 mM MgCl2 was 
replaced with 10 mM CaCl2, MnCl2, ZnCl2,or NaCl.  Melting temperatures could not be 
determined with MnCl2 or ZnCl2.  
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Figure 2.3  Circular dichroism spectroscopy was performed in standard DNAzyme buffer 
with 2 µM DNAzyme and 2 µM 19-nt RNA target with a 2′-OMe adenosine at the 
cleavage site.  Samples were pre-annealed by heating to 90 °C and cooling slowly to 
room temperature.  The asymmetric peak at 270 nm, the negative effect at 244 nm, and 
the peak at 223 nm are characteristic of DNAzyme / RNA hybrids.   
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Figure 2.5  Cleavage of the 28-nt RNA substrate by Dz0 or Dz8 was investigated in the 
presence of various metal ions.  P-32 labeled RNA was imaged on 7 M urea, 20% 
polyacrylamide gel after 1 h reaction with DNAzymes.  Single turnover assays were 
performed at 37 °C with 4.2 µM DNAzyme, 0.083 µM RNA in standard buffer with 10 
mM MgCl2, MnCl2, CaCl2, NaCl, or ZnCl2.   
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Figure 2.6  P-32 labeled RNA substrate on denaturing polyacrylamide gel 
electrophoresis (20% PAGE / 7 M urea).  Cleavage reactions were performed as 
described previously.  Standard DNAzyme buffer was substituted with buffers of various 
Mg2+ concentrations.   
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Figure 2.7  Full-length 10-23 DNAzyme and RNA substrate on denaturing 
polyacrylamide gel electrophoresis (20% PAGE / 7 M urea).  Single turnover assays were 
performed at 37 °C with a 50-fold excess of DNAzyme to RNA (1000 pmol : 20 pmol) in 
standard buffer with 10 mM or 0.01 mM MgCl2.  After one hour, the reaction was 
quenched with 10 µL RNA loading buffer II (Ambion).  The gel was stained with 
ethidium bromide for analysis. 
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Table 2.1  Ratio of RNA target cleaved by the intact (Dz0) and split (Dz8) DNAzymes, 
which also incorporated single base mismatches within the binding arms. These seven 
new sequences are labeled m1-m7, with mismatch sites underlined and shown in bold 
font. The gap in the middle of the sequences reflects where the split DNAzymes were 
divided. 
 
 
DNAzyme Sequences RNA 
Cleavage   
Intact Dz : 
Split Dz 
Dz0: tgctctccaGGCTAGCTACAACGAcctgcacct 
Dz8: tgctctccaGGCTAGCT ACAACGAcctgcacct 1.5 
 m1: tgctctccaGGCTAGCT ACAACGAcctgcacca 2.8 
 m2: tgctctccaGGCTAGCT ACAACGAcctgaacct 9.8 
 m3: tgctctccaGGCTAGCT ACAACGAactgcacct 5.2 
 m4: tgctctcaaGGCTAGCT ACAACGAcctgcacct 4.1 
 m5: tgctcaccaGGCTAGCT ACAACGAcctgcacct 4.4 
 m6: tgcactccaGGCTAGCT ACAACGAcctgcacct 3.1 
 m7: agctctccaGGCTAGCT ACAACGAcctgcacct 2.0 
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Figure 2.8  A) Full-length DNAzymes with single-base mismatches (m1-m7) show 
comparable activity to Dz0, which is fully complementary to the RNA target. B) Split 
DNAzymes with single-base mismatches (m1-m7) cleave greater than 20% of RNA only 
when the mismatch minimally perturbs hybridization, at either the 5′ or 3′ end.   
Sequences of enzymes with single base mismatches are provided in Table 1. Data are 
averages of three independent trials, with bars indicating the range of values. 
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Figure 2.9  A) Schematic of general structure and function of photoactivatable 
DNAzyme controlled by biotin-streptavidin interaction.  B) Structure of biotinylated 
photocleavable spacer.  C) Photocleavable DNAzyme assay.  Photocleavable biotinylated 
Dz8b and streptavidin were added to either Dz7a or Dz8a.  Samples were irradiated by 
UV transilluminator (9 mWcm-2 at 365 nm) for 20 minutes prior to addition of RNA.  
Reactions were incubated at 37 °C for one hour. 
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Figure 2.10  P-32 labeled RNA substrate on denaturing polyacrylamide gel 
electrophoresis (20% PAGE / 7 M urea).  Cleavage assay was performed as described 
previously.  The Dz8b half with a 5′-photocleavable biotin was used instead of the 
normal Dz8b.    
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Figure 2.11  P-32 labeled RNA substrate on denaturing polyacrylamide gel 
electrophoresis (20% PAGE / 7 M urea).  Cleavage assay was performed as described 
previously.  The Dz8b half with a 5′-photocleavable biotin was used instead of the 
normal Dz8b.   Dz7a or Dz8a with single base mismatches incorporated (Table 1) were 
tested.  All samples were irradiated by UV transilluminator (9 mWcm-2 at 365 nm) for 20 
minutes.  Streptavidin (100 pmol, equimolar with DNAzyme) was incubated in the 
reaction mixture at 37 °C for 30 minutes, P-32 labeled RNA substrate was added, and the 
reaction was allowed to proceed for one hour at 37 °C.   
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Chapter 3 
Caged hairpin-bandage hybrids for transcriptome in vivo analysis 
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I. Introduction 
a. Background 
The caged hairpins and bandages previously developed by our lab accomplished 
their basic purposes, but they both required a good deal of optimization to achieve high 
melting temperatures before photolysis and lower ones afterwards.  Unfortunately, there 
were also a number of other factors that determined how well each of these designs 
controlled gene expression.  For instance, there was no direct correlation between the 
change in melting temperature of the DNA hairpin and its ability to photo-regulate RNase 
H-mediated digestion of RNA[1].  Specifically, a variety of hairpins all comprised of the 
same 20mer antisense sequence but different lengths of blocking strands and different 
numbers of mismatched bases were synthesized.  When the hairpins were tested in vitro, 
it was discovered that the size of the loop formed by the photocleavable linker in joining 
the DNA to its blocking strand was a more important factor.  A similar problem was 
encountered with the RNA bandages; the bandages with the largest changes in melting 
temperature before and after photolysis were not the most effective in regulating gene 
expression.  The targeted region of mRNA was found to be more significant than 
thermodynamics[2].   
Due to the complexity of the biological systems we wish to study and the above-
mentioned factors that require optimization, it is difficult to determine the effectiveness 
of a given caged oligonucleotide.  This led us to combine the hairpin and bandage 
techniques to develop hairpin-bandage hybrids that would not require as much 
optimization of the length and sequence of the blocking strands.  By combining these two 
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approaches, we designed an antisense strand that is linked via a photocleavable spacer to 
a blocking strand that is divided into two parts by a second photocleavable spacer.  After 
UV irradiation, the blocking strand is broken into two shorter oligonucleotides, which can 
more easily dissociate from the antisense strand.  This design allows the blocking strand 
to be as long as possible before uncaging, efficiently blocking the antisense strand from 
binding to its mRNA target.   
Previous work by our lab has concentrated on utilizing caged oligonucleotides to 
gain control of gene expression.  However, the hairpin-bandage hybrids are being utilized 
to isolate mRNA from single neurons in culture and in mouse hippocampal slices.  For 
this work, we have been collaborating with the Eberwine lab in the Department of 
Pharmacology at the University of Pennsylvania.   
Research in the Eberwine lab focuses on studying RNA populations in neurons to 
gain a better understanding of central nervous system function and to learn how neurons 
respond to stimuli at the transcriptional level.  Studying RNA populations from single 
cells is important because, even though all cells contain the same DNA, their function 
and morphology differ greatly.  It has been shown that these phenotypic differences are 
associated with which RNAs are present and the level at which they are expressed[3].  
Unfortunately, it is very difficult to transfect single cells in a large population of cells 
using existing methods.  Therefore, a photoregulatable antisense oligonucleotide that 
could be transfected into an entire populations of cells but uncaged site-specifically in a 
single cell would be a valuable tool.  
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b. Current techniques for isolating neurons 
To date, there are a number of approaches for studying complex brain tissue.  
These include fluorescence activated cell sorting[4], immunopanning[5], translating 
ribosome affinity purification[6], manual sorting[7], laser capture microdissection[8], 
atomic force microscopy nanoprobe extraction[9], and isolation via patch pipette[10].  
Fluorescence activated cell sorting (FACS) was utilized to purify a genetically labelled 
population of neurons[4].  A transgenic mouse line, in which the mice contained an EGFP-
expressing cell-type-specific regulatory element, was developed.  Hippocampal slices 
from these mice were then enzymatically dissociated, and the neurons were subjected to 
FACS purification.  This process separated out only the neuronal population expressing 
EGFP, allowing for isolation of RNA from only the neuronal subtype of interest.   
Another method used to better understand brain development and function is 
immunopanning[5].  With this technique, brain cells suspended in buffer are added to an 
antibody-coated panning plate to remove cell types that adhere to the selected antibody.  
Sequential panning with additional antibodies is performed until the desired neural cell 
population, the oligodendrocyte lineage in this example[5], is isolated.  
Translating ribosome affinity purification (TRAP) is another process for purifying 
RNA from neurons.  Heiman et al. developed the TRAP methodology, which initially 
involves the development of a mouse line that expresses a transgene encoding EGFP 
fused to a ribosomal protein[6].  The transgene was designed to be under the control of a 
receptor expressed in a specific cell type, resulting in expression of affinity-tagged 
translating ribosomes in that cell population.  After dissection and homogenization of 
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hippocampal tissue, affinity purification of the ribosomes and their mRNA can be 
achieved using anti-GFP antibody-coated beads.  In an additional study, the TRAP 
method was expanded to profile 24 different CNS cell populations[11].   
An alternative technique involves manual sorting of reporter-labelled cells in 
dissociated cell culture[7].  By dissecting slices from the forebrains of transgenic mouse 
lines expressing fluorescent proteins in subsets of neurons, the authors suspended the 
cells in solution and successfully isolated fluorescent neurons under a dissecting 
microscope.  The purified sample was then lysed to attain RNA for analysis.    
Laser capture microdissection is a procedure that can be used for isolating RNA 
from a single cell[8]. In this technique, a transparent thermoplastic film is applied to tissue 
or cell cultures on a glass slide.  Then, a laser pulse is applied, melting the film to 
“capture” the cell(s) of interest, which can then be lysed and examined. 
Recently, atomic force microscopy (AFM) nanoprobes have been employed to 
extract RNA from single cells[9].  The single cell nanoprobe is inserted into the cell of 
interest to extract the cellular ingredients.  Unfortunately, limited access to an atomic 
force microscope has prevented this technique from gaining wide-spread use at this point. 
 Finally, the most commonly used approach is RNA isolation via patch pipette, 
which was developed by the Eberwine lab[10].  A patch pipette penetrates the cell 
membrane to microinject reverse transcriptase and an oligo(dT) primer with a T7 RNA 
polymerase promoter site into a single, live cultured primary hippocampal neuron[10a].  
The oligo(dT) primer is used to prime the poly(A)+ mRNA for cDNA synthesis by 
reverse transcriptase.  Then, the cellular contents are aspirated from the cell into the patch 
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pipette for the cDNA to be amplified using T7 RNA polymerase to transcribe RNA 
copies.   
Unfortunately, each of these techniques has disadvantages.  FACS and manual 
sorting can isolate single cells, but they are limited in that they do not provide any insight 
into the location of the cell in tissue.  LCM, the AFM nanoprobe method, and TRAP 
often suffer from RNA contamination from nearby cells, and TRAP only collects RNA 
that is associated with ribosomes.  The only approaches that can achieve single cell RNA 
isolation while still collecting information about the cellular physiological properties are 
LCM, AFM nanoprobe extraction, and patch-pipette isolation.  However, the small 
amount of mRNA that can be absorbed by the AFM probe makes this technique difficult 
to use, even when coupled with PCR.  Finally, patch-pipette mediated isolation is 
difficult to perform and it mechanically injures the surrounding tissue.  These drawbacks 
motivate the design of an approach that will isolate mRNA from single cells in vivo.       
c. Caged compounds for studying the central nervous system  
As discussed in chapter one, there are a number of advantages to utilizing light in 
biochemical studies.  Since photochemical processes are well-understood, light is 
orthogonal to biological processes, and both UV and visible light are minimally invasive, 
these compounds can be ideal for studying biological systems.  Furthermore, the high 
degree of spatiotemporal control these compounds afford can allow for time-resolved 
studies and for spatial resolution to study dendrites, synapses, and individual nuclei. 
These advantages have led other groups to apply light-activatable compounds to 
the study of the central nervous system (CNS).  For example, Lima et al. microinjected 
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DMNPE-caged ATP into the CNS of Drosophila to study the role of dopaminergic 
neurons in the control of movement; a pulse of laser light photoreleased the ATP which 
was then free to act as an agonist for an ion channel expressed in a set of neurons[12].  
Another approach to photocontrolling a neuronal ion channel was developed by the 
Kramer lab[13].  Their caged compound is comprised of a maleimide functional group (for 
cysteine tethering to the ion channel) and a quaternary ammonium group linked via a 
photoisomerizable azobenzene moiety.  In the trans form, the ammonium group can 
block the channel, but UV irradiation converts azobenzene to its cis form, rendering the 
compound too short to block the channel.  In other work, a caged AMPA (α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid) receptor antagonist was developed to 
monitor surface-exposed AMPA receptors in individual Xenopus oocytes[14] and in single 
cells in rat hippocampal cell cultures[15].   
d. Hairpin-bandage hybrid design strategy 
Considering the many advantages of caged oligonucleotides and the success in 
utilizing light-activatable moieties to probe the CNS, we sought to design hairpin-
bandage hybrids to isolate mRNA from single neurons, a technique we have coined 
Transcriptome In Vivo Analysis (TIVA).  Since the caged hairpin-bandage hybrids 
discussed in the remainder of this chapter are being used for TIVA, they will be referred 
to as “TIVA-tags” for the rest of this chapter.   
In designing TIVA-tags to isolate mRNA from individual neurons, we first chose 
to utilize a probe strand that could target the poly(A)+ tails of mRNA (Figure 3.1).  Since 
messenger RNAs (mRNAs) have 3′-polyadenine tails that aid in translation, we designed 
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an antisense strand consisting of uracils that can hybridize to this region of mRNA.  In 
previous work, the Eberwine lab developed a technique that employs peptide nucleic 
acids (PNAs) to isolate RNA strands associated with RNA-binding proteins[16].  The PNA 
hybridizes to RNA and then photo-crosslinks to the associated proteins.  Instead of using 
an antisense strand comprised of PNA, we chose a well-characterized, commercially 
available RNA analog with increased thermal stability, 2′-fluoro RNA.  Substitution of a 
fluoro group at the 2′-position locks the ribose ring into the 3′-endo conformation, which 
causes duplexes of the RNA to favor A-form helices and increases the melting 
temperature of the duplex 2 °C per base relative to DNA[17].   
 To develop a hairpin-bandage hybrid, two photocleavable spacers are 
incorporated to join the probe strand to two blocking strands (Figure 3.1).  Both blocking 
strands are comprised of 2′-OMe RNA, which also increases the thermal stability and 
nuclease resistance of the duplex.  Additionally a 3′-biotin tag and a 5′-thiol were added 
to the oligonucleotide.  Cy3 and Cy5 fluorophores were included to monitor dissociation 
of the oligonucleotide after photolysis.  These dyes are ideal because they do not absorb 
at wavelengths below 400 nm where the photocleavable spacer is activated.   
After successfully monitoring oligonucleotide dissociation in vitro, a cell-
penetrating peptide (CPP) was conjugated to the oligonucleotide via a disulfide linkage in 
order to transport the oligonucleotide into cells.  Upon entering the cell, the disulfide 
bond is reduced, allowing the peptide to dissociate from the hairpin.  In vivo FRET 
experiments have been performed in primary cultured neurons and mouse hippocampal 
slices.  Additionally, mRNA has been isolated from single neurons utilizing the TIVA-
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tag; by lysing the cells and adding magnetic streptavidin beads, it is possible to isolate the 
antisense strand bound to mRNA.  This allows the mRNA to be eluted by heating and 
amplified by the inverse transcription method developed by the Eberwine lab[18]. 
The studies presented in this chapter detail the in vitro characterization of TIVA-
tags and their in vivo application to isolate mRNA from single neurons both in primary 
culture and in mouse hippocampal slices.  Future, more extensive, biological analyses 
will allow for gene expression in single cells to be quantified, providing insight into how 
mRNA abundances vary temporally as well as spatially (e.g. in dendrites versus 
synapses).   
II. Experimental procedures 
a. Oligonucleotide synthesis and purification 
 Oligonucleotides were synthesized by standard phosphoramidite chemistry using 
an ABI DNA/RNA 394 nucleic acid synthesis system on 1.0 µmole or 10.0 µmole scales.  
Reagents obtained from Glen Research included 2′-Fluoro U (10-3430), 2′-OMe A (10-
3100), 5′-thiol C6 spacer (10-1936), Cy3 (10-5913), Cy5 (10-5915), and photocleavable 
spacer (10-4913) phosphoramidites, and a 3′-biotin TEG CPG (20-2955).  Coupling times 
were adjusted to manufacturer’s recommendations, and 0.02 M iodine was used for 
oxidation steps. 
 After cleavage and deprotection using ammonium hydroxide at room temperature 
for 24 hours, oligonucleotides were purified on an Agilent 1100S reverse-phase HPLC 
(C18 column) with eluents of 0.05 M triethylammonium acetate (A) and acetonitrile (B); 
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gradient, 0-40 minutes, 10-60% B, then 60-80% B in 40-50 minutes in A+B; flow rate, 1 
mL/min; 40 °C.  The retention time of the purified TIVA-tags with 5′-thiol modification 
was ~ 50 minutes.  Removal of the 4,4′-dimethoxytrityl group was performed by treating 
the purified oligonucleotides with 80% acetic acid for 20 minutes at room temperature.  
The TIVA-tag was desalted on a Nap-5 column (GE Healthcare) and dried under 
vacuum.  
b. Conjugation of TIVA-tags to cell-penetrating peptides 
The method of conjugating oligonucleotides to CPPs through disulfide bonds was 
modified from Turner et al[19].  Briefly, 5 nmol of oligonucleotide with 5′-thiol 
modification was deprotected using 50 mM TCEP for two hours.  The TCEP was 
removed by desalting on a NAP-5 column (GE Healthcare), and the oligonucleotide was 
dried under vacuum.  After drying, the oligonucleotide was redissolved in 50 µL of 0.33 
M TEAA, 150 µL of formamide was added, and the sample was vortexed.  Two CPPs, 
(D-Arg)9 and Tat (YGRKKRRQRRR-NH2), each with a cysteine activated with a 3-nitro-
2-pyridinesulfenyl group (Npys) on the C-terminus, were obtained from Anaspec.  CPPs 
were dissolved at a concentration of 1 mM in water.  To the dissolved oligonucleotide, a 
four-fold excess of CPP was added, and the reaction was allowed to proceed overnight at 
room temperature. 
The conjugation product was purified by anion exchange on an Agilent 1100S HPLC 
using a 1 mL Resource Q column with a flow rate of 1 mL/min and a gradient of 0-100% 
buffer B in 30 minutes (buffer A:  20 mM Tris-HCl (pH 6.8), 50% formamide; buffer B:  
20 mM Tris-HCl (pH 6.8), 50% formamide, 400 mM NaClO4).  Finally, the product was 
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desalted on a NAP-5 column, dried under vacuum, and characterized by MALDI-TOF 
mass spectrometry at the Wistar Institute Proteomics Facility.   
c. Mass analysis of TIVA-tags 
Matrix-assisted laser desorption/ionization (MALDI) of TIVA-tags was 
performed at the Wistar Institute Proteomics Facility at the University of Pennsylvania.  
Mass spectra were recorded on an Applied Biosystems Voyager System 6030 MALDI-
TOF mass spectrometer operated in negative mode with 3-hydroxypicolinic acid matrix.  
In addition to peaks that correspond to full-length products, peaks consistent with masses 
of fragments from photocleavage reactions are present in the MALDI spectra.  This is 
due to UV pulse laser irradiation required for MALDI-TOF and has been observed 
previously when characterizing light-activatable oligonucleotides[20].   
d. Melting point determinations 
 Melting point studies were conducted on a Beckman Coulter DU800 UV-Vis 
spectrophotometer equipped with a programmable Peltier temperature controller.  
Samples were monitored at 260 nm while heating or cooling at a rate of 1.0 °C/min, with 
a one minute hold per degree Celsius.  Melting temperatures were determined from the 
peak of the first derivative plot of Abs260 vs. temperature. 
 TIVA-tags were prepared at 1 µM concentration in 10 mM Tris pH 7.5 with 300 
mM NaCl and 10 mM MgCl2.  To ensure the oligonucleotides were properly annealed, 
the samples were heated to 90 °C in a water bath for five minutes, then slowly cooled to 
room temperature over approximately three hours.  For samples that were photolyzed, 
irradiation was carried out using a UV transilluminator (Spectronics Corporation TL-
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365R) at wavelengths centered on 365 nm (9 mW/cm2 at peak intensity) for 15 minutes 
with the samples in open 200 µL microcentrifuge tubes. 
e. FRET analysis of Cy3/Cy5 labeled TIVA-tags 
TIVA-tags with Cy3/Cy5 FRET fluorophores and TIVA-tags with only Cy3 or 
only Cy5 were prepared at 1 µM concentration in the same buffer as for the melting point 
determination experiments, and photolysis was carried out as discussed above.  The 
samples were pre-hybridized, and measurements were made in a sub-micro cuvette that 
was incubated at 37 °C during emission collection.  The fluorescence emissions of Cy3 at 
565 nm and Cy5 at 667 nm, upon excitation at 552 nm, were monitored by a Varian 
Eclipse fluorimeter (scanning rate of 120 nm/min, and averaging time of 0.5000 sec).   
f. Polyacrylamide gel electrophoresis analysis of TIVA-tags 
Caged and uncaged TIVA-tag samples (200 pmol in 5 µL water and 5 µL 
formamide) were loaded onto 20 % polyacrylamide, 7 M urea gel.  The following 
irradiation conditions were tested:  405 nm laser for 100 µsec per pixel for an image of 
512 x 512 pixels; UV laser (351 nm and 364 nm laser lines) for 100 msec, 5 sec, or 10 
sec; and UV transilluminator for 15 minutes.  Gels were electrophoresed at 300V for 45 
minutes, and staining was performed with ethidium bromide for ten minutes.  Gels were 
imaged on a Bio-Rad Gel Doc 2000 system or a GE Typhoon imaging system. 
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III. Results and discussion 
a. TIVA-tag characterization 
In a preliminary experiment, an 18mer 2′-F strand of all uracils with a biotin tag 
was capable of isolating RNA in pull-down assays (unpublished data, Eberwine lab).  To 
choose an initial blocking strand length, the melting temperature of an 18mer 2′-F RNA 
strand of all uracils against different strand lengths of all adenines found the melting 
temperature of the poly(U) strand against a 7mer 2′-OMe strand of adenines to be 
approximately 24 °C, which is much lower than the temperature used in cell experiments 
(Julia Richards, 2010, Development of photoactivatable oligonucleotides, Doctoral 
dissertation).  Therefore, the first TIVA-tag without dyes was synthesized with an 18mer 
uracil antisense strand and two 7mer blocking strands (Figure 3.2A), and it was 
characterized by MALDI mass spectrometry at the Wistar Proteomics Facility (Table 
3.1).  Thermal denaturation experiments demonstrated that the TIVA-tag has a pre-
photolysis melting temperature of 53.9 °C and a post-photolysis melting temperature of 
30.2 °C (Table 3.2, Figure 3.3A).  However, the post-photolysis melting temperature is 
difficult to assign since the curve is not sigmoidal in shape.  This was also the case with 
the 18mer 2′-F RNA strand of all uracils against the 7mer 2′-OMe strand of adenines 
tested by Dr. Richards (Julia Richards, 2010, Development of photoactivatable 
oligonucleotides, Doctoral dissertation).  Since the same experiment performed with a 
9mer 2′-OMe strand instead of a 7mer resulted in a sigmoidal shaped curve and a melting 
temperature of 31 °C, we determined that the post-photolysis melting temperature of the 
TIVA-tag is too low to measure accurately.  This is because the spectrophotometer’s 
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Peltier temperature controller could not cool samples below 15 °C.  The short lengths of 
oligonucleotides produced after photocleavage should have low melting temperatures, 
making it difficult to measure them using this apparatus.  While this limitation should be 
noted, we are actually most interested in the pre-photolysis melting temperature since all 
of the post-photolysis melting temperatures are lower than the 37 °C required for cellular 
experiments. 
Since there did seem to be a large change in melting temperature (∆Tm) for the 
TIVA-tag without dyes, a fluorescently-labeled version of the TIVA-tag (with Cy3 and 
Cy5 dyes) was synthesized.  This TIVA-tag also had a seemingly large ∆Tm with a 
calculated melting temperature of 59.0 °C before photolysis and 29.0 °C after uncaging 
(Table 3.2, Figure 3.3B), but the post-photolysis melting curve was also not sigmoidal in 
shape.  However, since we were confident that the post-photolysis melting temperature is 
below 37 °C, we chose to fully characterize the dye-labeled TIVA-tag.   
While testing the original fluorescently-labeled TIVA-tag, we also synthesized 
and characterized (Figure 3.2, Table 3.1) TIVA-tags with various lengths of antisense and 
blocking strands to see if we could generate larger pre-photolysis melting temperatures 
since some of our lab’s previously designed hairpins had melting temperatures of 
approximately 70 °C.  We also introduced a C6 spacer between the 2′-F antisense strand 
and the first photocleavable linker to see if the increased flexibility in the loop of the 
hairpin would result in a change in melting temperature, but it had little effect (<1 °C) on 
the melting temperature (Table 3.2, Figure 3.4A).  For the original 18mer antisense 
strand, the pre-photolysis melting temperature increases ~7 °C if the blocking strand 
lengths are increased to eight adenines each (Table 3.2, Figure 3.4B).  On the other hand, 
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decreasing the length of the blocking strands or using two blocking strands of different 
lengths resulted in a decrease in melting temperature before photolysis
 
(Table 3.2, Figure 
3.4C-3.4F).   
TIVA-tags with longer antisense strand lengths were also synthesized.  When a 
TIVA-tag with a 20mer antisense strand and two 7mer blocking strands was examined, it 
was found to have a lower pre-photolysis melting temperature than the original TIVA-tag 
(Table 3.2, Figure 3.4G).  Increasing the number of uracils to 20 or 22 increased the pre-
photolysis melting temperature when 9mer blocking strands were used (Table 3.2, Figure 
3.4H-3.4I).  Both of these uncaged constructs had a melting temperature of ~65 °C.   
Finally, we performed thermal denaturation studies on TIVA-tags comprised of 
all 2′-F RNA bases or all 2′-OMe RNA bases.  When the original TIVA-tag was 
designed, 2′-F RNA phosphoramidites were more expensive to purchase, so 2′-F uracils 
were only used to synthesize the antisense strand.  We chose to synthesize the blocking 
strands with 2′-OMe RNA.  Now, however, the analogues are similar in cost, so we 
synthesized TIVA-tags to determine if it would be preferable to use one analogue over 
the other.  Since these TIVA-tags had lower pre-photolysis melting temperatures than the 
original TIVA-tag (Table 3.2, Figure 3.4J-3.4K), we determined that it is not preferable 
to use one only one analogue. 
b. In vitro FRET monitoring of TIVA-tag dissociation 
To monitor the dissociation of the Cy3/Cy5-labeled TIVA-tag after photolysis, we 
measured the fluorescence spectrum and calculated the FRET efficiency (Figure 3.5A).  
The FRET efficiency was defined as:  Ia / ((γ*Id)+Ia), where Ia is the intensity of the 
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acceptor (Cy5) fluorescence, Id is the intensity of the donor (Cy3) fluorescence, and γ is 
the correction factor for the difference in donor and acceptor quantum yields (the 
quantum yields for Cy3 and Cy5 are 0.15 and 0.3, respectively).  In addition to collecting 
the emission spectra for the Cy3/Cy5 TIVA-tag, fluorescence experiments were 
performed with a Cy5-only TIVA-tag (Figure 3.5B) and a Cy3-only TIVA-tag (Figure 
3.5C) to measure any decrease in fluorescence intensity due to irradiation at 365 nm for 
uncaging.  By subtracting the Cy5 emission spectrum upon excitation at 552 nm from 
that of the Cy3/Cy5 TIVA-tag, any contribution of Cy5 emission by direct excitation, 
rather than energy transfer, was eliminated.  To calculate the FRET efficiency, the 
average of three independent trials with the Cy5-only TIVA-tag was subtracted from the 
average of three trials with the Cy3/Cy5 TIVA-tag, and the corrected emission spectra 
were graphed and analyzed (Figure 3.5A).  The FRET efficiency was found to be 0.8307 
before photolysis and 0.08851 afterwards.  This is a 74 % change in FRET efficiency, 
indicating a conformational change in the TIVA-tag, i.e. a lysis of the oligonucleotide 
into separate parts.  Emission spectra of both the Cy3/Cy5 TIVA-tag and the Cy5-only 
TIVA-tag excited at 643 nm were also collected to monitor the direct excitation of Cy5 
dye in each case (Figure 3.5D-3.5E). 
c. Gel analysis of TIVA-tag uncaging 
We also verified oligonucleotide dissociation post-photolysis by denaturing 
polyacrylamide gel electrophoresis (PAGE) (Figure 3.6A).  TIVA-tags before or after 
photolysis were loaded in a 20% PAGE, 7M urea gel, which was electrophoresed at 300V 
for 45 minutes.  Staining with ethidium bromide for ten minutes revealed bands 
corresponding to intact TIVA-tag and photolysis products.  Only one band was present 
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for the caged TIVA-tag sample.  Samples irradiated with a 405 nm laser or for five or ten 
seconds with a UV laser displayed two photolysis bands that ran faster on the gel than the 
caged oligonucleotide, but there was also some caged TIVA-tag present.  Irradiation for 
100 msec with the UV laser uncaged very little TIVA-tag.  Finally, irradiating for 15 
minutes with a UV transilluminator completely uncaged the TIVA-tag, as can be 
determined by the presence of only two photolysis product bands on the gel.  The two 
photolysis products seen on the gel correspond to the 3′ end of the TIVA-tag with either 
one photocleavable group (the highest photolysis band) or two photocleavable groups 
(the lowest photolysis band) cleaved.  This was confirmed by a denaturing 
polyacrylamide gel imaged with a GE Typhoon Imager using the fluorescence setting 
(Figure 3.6B).  In this gel, both photolysis products fluoresce green, indicating the 
presence of the Cy3 dye.  The band for the uncaged TIVA-tag appears yellow due to the 
overlap of the Cy3 and Cy5 (shown in red) dyes (Figure 3.6B). 
d. Preparation of TIVA-tags for cellular experiments  
To facilitate the cellular uptake of TIVA-tags we conjugated them to cell-
penetrating peptides (CPPs).  Preliminary experiments performed by Dr. Ditte Lovatt in 
the Eberwine lab discovered that fluorescently-labeled (specifically 
carboxytetramethylrhodamine-labeled) Tat and (D-Arg)9 CPPs at a concentration of 10 
µM efficiently transduced the dye into cortical cultured neurons (Unpublished results, 
Eberwine lab).  Therefore, we chose to conjugate TIVA-tags to these CPPs via disulfide 
bonds following a protocol modified from work done by Turner et al[19].   
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Following the conjugation reaction, TIVA-tag conjugates were purified by anion 
exchange chromatography using highly denaturing conditions (50% formamide) in order 
to prevent excess cationic CPP from remaining bound to the negatively charged 
oligonucleotide and to prevent precipitation.  Typical HPLC chromatograms show that 
compared to the reduced oligonucleotide alone (Figure 3.7A), both the (D-Arg)9 -
conjugated TIVA-tag (Figure 3.7B) and the Tat-conjugated TIVA-tag (Figure 3.7C) 
eluted a couple of minutes earlier at approximately 22 minutes.  These results are 
consistent with the earlier elution time for conjugates observed by Turner et al. for their 
CPP-oligonucleotide conjugates[19].  After desalting and drying the conjugates under 
vacuum, they could be redissolved in water, that their masses were confirmed by 
MALDI-TOF mass spectrometry.  The masses of (D-Arg)9-TIVA-tag and Tat-TIVA-tag 
were found to be 14,430.31 and 14,432.46, respectively (compared to expected masses of 
14,412.7 and 14,547.8, respectively) (Figure 3.8).     
e. In vivo studies 
Our collaboration with the Eberwine lab has enabled us to test TIVA-tags in 
dispersed primary neuron cell culture and acute mouse hippocampal slices.  The initial 
aim was to monitor the change in FRET in cultured neurons.  By incubating cultured 
cortical neurons (prepared for 7-12 days in vitro), with 10 µM (D-Arg)9-TIVA-tag for ten 
minutes, a decrease in Cy5 intensity and increase in Cy3 intensity in a single neuron was 
observed after irradiation with a 405 nm laser (Figure 3.9, in collaboration with Dr. Ditte 
Lovatt).   
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Next, we moved on to investigate whether TIVA-tag dissociation could be 
monitored in hippocampal tissue.  While cultured neurons are very useful for single cell 
studies, there are significant differences between cultured cells and intact tissues.  For 
instance, cultured cells are grown on 2-D plates, so they lack the inherent 3-D 
morphology of tissue.  Additionally, cellular organization and neuronal connections are 
maintained in tissue but not cultured cells.  Due to these inherent differences and the fact 
that live tissue slices are more similar to the intact brain, it would be highly beneficial to 
be able to isolate mRNA from single neurons in live tissue.   Therefore, we incubated live 
hippocampal slices from a 60-day old mouse for 40 minutes with 10 µM (D-Arg)9-TIVA-
tag.  After uncaging the TIVA-tag with a 405 nm laser, there is a significant increase in 
Cy3 fluorescence and a decrease in Cy5 fluorescence intensity, indicating dissociation of 
the TIVA-tag (Figure 3.10, in collaboration with Dr. Jai-Yoon Sul).   
In addition to monitoring TIVA-tag photolysis in vivo, mRNA has been isolated 
successfully from a single neuron from a live slice.  After incubating a slice from a 60-
day old mouse with TIVA-tag and uncaging the TIVA-tag in a single neuron, the cells 
were lysed, and magnetic streptavidin beads were added to pull-down the antisense strand 
still bound to mRNA.  Next, the oligonucleotides were heated to greater than 50 °C to 
elute the mRNA since the melting temperature of an 18mer 2′-F uracil oligonucleotide 
tagged with Cy3 and 3′-biotin against an 18mer poly(A)+ RNA strand was found to be 50 
°C (Figure 3.11).  Finally, the RNA was amplified using the antisense RNA amplification 
procedure[10], the RNA was cleaved into smaller fragments, and the material was loaded 
onto a nanochip gel and electrophoresed in a nanochip bioanalyzer.  As shown in Figure 
3.12, the uncaged TIVA-tag was successful in isolating mRNA from a single neuron, and 
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there was minimal RNA background from an uncaged neuron (Figure 3.12, in 
collaboration with Dr. Peter Buckley).  Ongoing sequencing analysis of the isolated RNA 
will enable us to qualitatively compare what RNA sequences the TIVA-tag is isolating, 
but preliminary results indicate that the TIVA-tags are pulling down RNA comparable to 
the patch pipette method and that the isolated RNA population is not rich in poly(A)+ 
sequences.  However, the real strength of the TIVA-tag is that it is capable of isolating 
RNA from live tissue, which is a limitation of current RNA isolation approaches.   
IV. Conclusions 
The goal of combining the photoactivatable hairpins and bandages previously 
developed by our lab was to develop a hairpin with a longer blocking strand but that 
retains a low melting temperature after photolysis.  Thus far, this approach has been 
successful in the case of our original TIVA-tag.  In addition to the large change in 
melting temperature, the first generation TIVA-tag has been used successfully in vivo.  In 
our studies with cultured neurons and live hippocampal slices, there appears to be 
minimal background prior to photolysis, suggesting that the TIVA-tag is stable in cells. 
To investigate whether the basic TIVA-tag design could be improved upon, 
particularly as other biological uses are developed, we synthesized and characterized 
TIVA-tags with various lengths of antisense and blocking strands.  Since the first 
generation TIVA-tag has a lower pre-photolysis melting temperature (60 °C) compared to 
our lab’s successful caged hairpins (~70 °C), it is possible that the TIVA-tag design may 
need to be optimized, focusing on increasing its stability before uncaging to ensure that 
no RNA is collected before photolysis.  Upon investigating other designs, it was 
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determined that new TIVA-tags with the largest pre-photolysis melting temperatures are 
the 18mer antisense strand with 8mer blocking strands and the 20mer probe with 9mer 
blocking strands.   
Also, we have started to consider more extensive modifications that can be made 
in the development of second generation TIVA-tags.  These include introducing new 
targeting moieties for optimizing specificity for particular cell types or cellular locations, 
changing to caging moieties like those with two-photon capabilities to optimize 
spatiotemporal control, and attempting to increase the thermal stability of the TIVA-tag 
by adding G-C residues to the 3′or 5′-end of the poly(U)/poly(A)+ strands.   
Thus far, work has only begun on considering other methods for targeted delivery 
of TIVA-tags.  An obvious possibility for new targeting moieties, due to the increased 
commercial availability of CPPs, would be to conjugate other CPPs to the TIVA-tag to 
target specific cell types.  Another option we have started to explore is folate receptor 
delivery.  Folate receptors are highly selective tumor markers that are commonly 
overexpressed in cancer cells, particularly ovarian cancer cells[21].  Folate receptors have 
a high-affinity for folic acid, which has been utilized as a receptor mediated delivery 
agent for cargo, such as antibodies[21], contrast agents[21], and oligonucleotides [22].  This 
is because folate is able to retain its receptor binding properties when conjugated to a 
biomolecule via its γ–carboxyl.  Therefore, we synthesized a folate-conjugated TIVA-tag 
(Figure 3.13), which may open the door for utilizing TIVA-tags to study mRNA 
specifically from cancer cells, if its in vivo use can be optimized.   
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Another obvious extension is to apply the hairpin-bandage hybrid approach to 
traditional antisense applications.  One such possibility is to inhibit microRNA activity.  
microRNAs (miRNAs) are short, double stranded RNA molecules comprised of 21-23 
nucleotides with two nucleotide 3′overhangs which regulate gene expression.  Let-7 was 
the first known miRNA; it was discovered in C. elegans and is evolutionarily conserved.  
It is an interesting target because it has been shown to target several known oncogenes, 
making it an interesting subject for cancer research[23].  Preliminary work in our group 
has focused on photomodulating let-7 miRNA activity using the hairpin-bandage hybrid 
design.  To this end, we have caged a 2′-OMe strand that is antisense to the let-7 miRNA 
sequence using two photocleavable groups to divide the blocking strand into two parts 
(Figure 3.14).  A FRET pair was also incorporated in order to monitor dissociation.  The 
field of photoregulating microRNA has only recently been explored. The Li lab has 
developed an oligonucleotide design similar to our caged hairpins where they have a 2′-
OMe RNA antisense strand that blocks a miRNA of interest linked to a blocking strand 
via a bifunctional caged linker[24].  Since their antisense strand was not fully blocked, a 
small amount of background activity was observed before photolysis.  If the change in 
melting temperature for the caged miRNA inhibitor can be optimized, the hybrid design 
should be a better approach because there should not be any background activity due to 
complete blockage of the antisense strand.  Future work in our lab will include 
characterizing and testing this caged miRNA in zebrafish embryos. 
In conclusion, we have developed a new method for utilizing two photocleavable 
linkers to lower the melting temperature of oligonucleotides after photolysis.  We have 
also monitored oligonucleotide dissociation, both in vitro and in vivo, using a FRET pair.  
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Finally, we have successfully employed the first generation of TIVA-tags to pull-down 
mRNA from single neurons.  Future work will focus on further developing the next 
generation TIVA-tags in addition to creating other hairpin-bandage hybrids for a variety 
of applications.  
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Figure 3.1  Schematic representation of TIVA-tag before and after photolysis.  A 2′-F 
RNA strand (blue) is caged via a photocleavable linker (red) to two shorter 
complementary 2′-OMe RNA strands (green) which are joined by a second 
photocleavable linker (red).  The 2′-F RNA strand is labeled with a biotin moiety, and a 
cell-penetrating peptide (CPP) is connected to the 5′-end of the 2′-OMe RNA strand by a 
disulfide bond.  After photolysis, the 2′-OMe RNA strand breaks into two shorter 
oligonucleotides, which then dissociate from the 2′-F RNA.  Dissociation can be 
monitored by means of the Cy3 (pink) and Cy5 (purple) dyes on the 2′-F RNA and 2′-
OMe RNA strands, respectively.  Finally, the 2′-F RNA can hybridize to the poly(A)+ tail 
of mRNA (gray) in the cell.   
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Figure 3.2  Structures of TIVA-tags:  A) General structure of TIVA-tags with various 
probe and blocking strand lengths, B) TIVA-tag with Cy3/Cy5 dyes, which was utilized 
for in vitro and in vivo experiments.   
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Table 3.1  Table of TIVA-tags and masses determined by MALDI-TOF mass 
spectrometry.   
 
TIVA-tag Expected Mass 
(g/mol) 
Measured Mass 
(g/mol) 
TIVA (no dyes) 11,862.7 11,851.49 
Cy-TIVA 13,019.9 13,047.06 
Arg-Cy-TIVA 14,412.7 14,430.31 
Tat-Cy-TIVA 14,547.8 14,432.46 
Folate-Cy-TIVA 13,165.7 13,209.02 
Cy5-TIVA 12,499.9 12,604.22 
Arg-Cy5-TIVA 13,892.7 13,952.62 
All 2'-F TIVA 11,708.2 11,673.49 
All 2'-OMe TIVA 12,093.4 12,086.65 
18U/6A/6A TIVA 11,058.2 11,134.18 
18U/8A/8A TIVA 12,431.2 12,489.78 
20U/7A/7A TIVA 12,493.0 12,602.78 
20U/9A/9A TIVA 13,733.0 13,800.85 
22U/9A/9A TIVA 14,482.3 14,487.06 
18U/7A/5A TIVA 11,190.2 11,218.53 
18U/5A/7A TIVA 11,190.2 11,211.94 
18U/7A/9A TIVA 12,563.2 12,569.06 
C6 Spacer TIVA 12,152.8 12,178.03 
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Table 3.2  Melting temperatures of TIVA-tags.  Oligonucleotide concentration of 1 µM 
in 10 mM Tris pH 7.5 buffer with 300 mM NaCl and 10 mM MgCl2 was used for all 
experiments. 
 
TIVA-tag Pre-photolysis Melting 
Temperature (°C) 
TIVA (no dyes) 53.9 
Cy-TIVA 59.0 
Arg-Cy-TIVA 52.0 
Tat-Cy-TIVA 49.9 
Folate-Cy-TIVA 56.8 
Cy3-TIVA 58.1 
Cy5-TIVA 59.1 
All 2'-F TIVA 54.0 
All 2'-OMe TIVA 53.1 
18U/6A/6A TIVA 56.4 
18U/8A/8A TIVA 61.0 
20U/7A/7A TIVA 51.5 
20U/9A/9A TIVA 64.8 
22U/9A/9A TIVA 64.8 
18U/7A/5A TIVA 41.2 
18U/5A/7A TIVA 44.6 
18U/7A/9A TIVA 55.5 
C6 Spacer TIVA 54.9 
 
Thermal denaturation curves for TIVA-tags after photolysis were not sigmoidal in shape.  
Therefore, it was not possible to assign melting temperatures to the TIVA-tags after 
photolysis.  This is likely due to the fact that the Peltier temperature controller was unable 
to cool the samples to temperatures lower than 15 °C, and the short oligonucleotides 
produced after photolysis should have melting temperatures of less than  30 °C. 
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Figure 3.3  Thermal denaturation curves for TIVA-tag A) without dyes, B) with 
Cy3/Cy5 dyes, and C) with only Cy3 or only Cy5 dyes before and after photolysis at 365 
nm.  TIVA-tags were hybridized in standard buffer, and melting temperatures were 
determined from the peak of the first derivative plot of Abs260 versus temperature.  The 
melting temperature for the TIVA-tag without dyes were found to be 53.9 °C pre-
photolysis.  For the TIVA-tag with dyes, the before photolysis melting temperature was 
59.0 °C.   
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Figure 3.4  Thermal denaturation curves of TIVA-tags with A) C6 spacer, B-I) various 
sense and antisense strand lengths, J) all 2′-F residues, and K) all 2′-OMe  residues before 
and after photolysis at 365 nm.  TIVA-tags were hybridized in standard buffer, and 
melting temperatures were determined from the peak of the first derivative plot of Abs260 
versus temperature.   
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Figure 3.5  Emission spectra of TIVA-tags before and after photocleavage.  TIVA-tags 
were prepared in standard buffer and hybridized prior to FRET analysis.  Fluorescence 
emission spectra were collected at 37 °C.  A) The emission spectra of the Cy5-only 
TIVA-tag upon excitation at 552 nm were subtracted from the original wavelength scans 
of the Cy3/Cy5 TIVA-tag also excited at 552 nm to correct for any direct excitation of 
Cy5 dye (not due to energy transfer). The FRET efficiency was found to be 83.1 % 
before photolysis and 8.9 % post-photolysis, which is a 9.4-fold decrease in FRET 
efficiency.  B) Emission spectra of Cy5-only TIVA-tag upon excitation at 552 nm.  C) 
Emission spectra of Cy3-only TIVA-tag upon excitation at 552 nm.  D) Emission spectra 
of Cy3/Cy5 TIVA-tag excited at 643 nm.  E) Emission spectra of Cy5-only TIVA-tag 
excited at 643 nm.  Each spectrum (full lines) is the average of three independent trials, 
and each graph also includes a spectrum of the minimum (dotted lines) and maximum 
values (dashed lines) of the three trials.   
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Figure 3.6  Denaturing PAGE (20%) analysis of TIVA-tags before and after uncaging.  
A) 200 pmol of oligonucleotide were loaded per well, gel was electrophoresed at 300 V 
for 45 minutes, and staining was performed with ethidium bromide for ten minutes.  (1) 
Non-irradiated TIVA-tag; (2) TIVA-tag + irradiation with 405 nm laser; (3) TIVA-tag + 
100 msec irradiation with UV laser; (4) TIVA-tag + 5 sec irradiation with UV laser; (5) 
TIVA-tag + 10 sec irradiation with UV laser; (6) TIVA-tag + 15 min irradiation with UV 
transilluminator.  B) 200 pmol of oligonucleotide were loaded per well, gel was 
electrophoresed at 300 V for 45 minutes, and gel was imaged with a GE Typhoon Imager 
using the fluorescence setting.  (1) Non-irradiated TIVA-tag; (2) TIVA-tag + irradiation 
with 405 nm laser.  Green indicates Cy3 dye, and red represents Cy5 dye. 
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Figure 3.8  MALDI-TOF analysis of CPP-conjugated TIVA-tags.  A) Mass spectrum of 
(D-Arg)9-TIVA-tag.  The peak at 14,430.31 corresponds to the intact (D-Arg)9-TIVA-tag 
(expected mass is 14,412.7).  B)  Mass spectrum of Tat-TIVA-tag.  The peak at 
14,432.46 corresponds to the intact Tat-TIVA-tag (expected mass is 14,547.8).  In both 
spectra, lower mass peaks are indicative of photolysis products resulting from 
oligonucleotide cleavage due to MALDI laser exposure.   
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Figure 3.9  Uncaging of TIVA-tag in the body of a single cultured neuron.  Cultured 
cortical neurons (7-12 days in vitro) were incubated with 10 µM (D-Arg)9-TIVA-tag.  
Irradiation was performed at 405 nm to uncage the oligonucleotide.  Emission from 532 
nm to 707 nm was collected after excitation at 514 nm. 
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Figure 3.10  Activation of TIVA-tag in a single dendrite and an individual cell soma in 
the live brain slice preparation from a 60-day old mouse.  Slices were incubated with 10 
µM (D-Arg)9-TIVA-tag.  The arrow points to the dendrite in which the TIVA-tag was 
uncaged with 405 nm light.  The inset shows a single cell soma in which TIVA-tag is 
irradiated at 405 nm.  Both the dendrite and the cell soma were excited at 514 nm, and 
emission from 532 nm to 707 nm was collected.  Cy5 fluorescence is indicated by red, 
and Cy3 fluorescence is shown in green. 
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Figure 3.11  Thermal denaturation curve of an 18mer 2′F-U strand with Cy3 dye and 
biotin at the 3′-end hybridized to 18mer poly(A)+ RNA strand.  Oligonucleotides were 
hybridized in standard buffer, and melting temperatures were determined from the peak 
of the first derivative plot of Abs260 versus temperature.  The melting temperature was 
found to be 50.2 °C. 
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Figure 3.12  Representative nanochip analysis of mRNA isolated from a single neuron.  
After TIVA-tag isolation from a single neuron in the live slice preparation, the mRNA 
was amplified using the antisense RNA amplification procedure.  Then, the RNA samples 
were then cleaved into smaller fragments and loaded on a nanochip gel and 
electrophoresed in a bioanalyzer.  The left lane is the RNA ladder.  The sample in the 
caged lane was isolated from a cell that was not irradiated, so it serves as the control.  
The uncaged sample represents RNA isolated from a single neuron. 
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Figure 3.13  Structure of folate-conjugated TIVA-tag with Cy3 and Cy5 dyes. 
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Figure 3.14  Structure of hairpin-bandage hybrid targeting let-7 microRNA. 
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I. Design strategy 
As discussed in chapter one, there is a demand for the development of light-
activatable approaches for controlling gene expression, and many recent advances have 
been made in controlling RNA interference (RNAi) with light[1].  This is a desirable 
approach because it is not challenging to design siRNA sequences for any gene of 
interest, and very small amounts of material are required (on the order of pmol).  
Unfortunately, many of the early caged siRNA designs were unable to completely block 
siRNA activity prior to irradiation[1c, 1e].  A more recent advance has ameliorated RNAi 
inhibition pre-photolysis using a new photocleavable group, cyclo-dodecyl DMNPE (CD-
DMNPE) [2].  Incorporation of this photolabile group at both the 3′ and 5′ ends of the 
sense and antisense strands of an siRNA duplex prevents any RNAi prior to irradiation.  
However, this caging strategy requires a lengthy synthesis.  Therefore, we sought to 
design a siRNA duplex that is fully blocked the 3′ and 5′ ends, but that involved a simpler 
synthesis strategy.   
In our design, a siRNA that incorporates two photoactivatable groups linking a 2′-
fluoro (2′-F) antisense strand targeting EGFP and a 2′-F/DNA chimera blocking strand 
was synthesized entirely by solid-phase synthesis (Figure S1.1) and characterized by 
MALDI-TOF (Figure S1.2).  Previous studies have demonstrated that 2′-F siRNA has 
increased nuclease resistance in vitro and in vivo (compared to unmodified RNA) and is 
equally effective at gene suppression[3].   Blidner et al. have demonstrated that a fully 2′-
fluoronated siRNA can elicit RNAi with similar activity to unmodified RNA when they 
photoregulated a siRNA.  However, since they were using the DMNPE group, their 
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approach also suffered from siRNA activity prior to photolysis.  To fully block any 
activity from the caged construct, we circularized the duplex by ligation with Circligase 
enzyme to fully block the 3′ and 5′ ends (Figure S1.3).  
II. Experimental procedures 
a. Oligonucleotide synthesis and purification 
Oligonucleotides were synthesized by standard phosphoramidite chemistry using 
an ABI DNA/RNA 394 nucleic acid synthesis system on a 1.0 µmol scale.  Reagents 
were obtained from Glen Research, coupling times were adjusted to manufacturer’s 
recommendations, and 0.02 M iodine was used for oxidation steps.  After cleavage and 
deprotection with ammonium hydroxide at room temperature for 24 hours, 
oligonucleotides were purified on an Agilent 1100S reverse-phase HPLC (C18 column) 
with eluents of 0.05 M triethylammonium acetate (A) and acetonitrile (B); gradient 0-40 
minutes, 10-60% B in A+B; flow rate, 1 mL/min.  The retention time for the purified 
product is ~30 minutes.  Removal of the 4,4`-dimethoxytrityl group was performed by 
treating the purified oligonucleotides with 80% acetic acid for 20 minutes at room 
temperature and drying under vacuum. 
b. Mass analysis of caged siRNA  
Matrix-assisted laser desorption/ionization (MALDI) was performed at the Wistar 
Institute Proteomics Facility at the University of Pennsylvania.  Mass spectra were 
recorded on an Applied Biosystems Voyager System 6030 MALDI-TOF mass 
spectrometer operated in negative mode with 3-hydroxypicolinic acid matrix.  In addition 
to the peak that corresponds to full-length product, peaks consistent with masses of 
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fragments from photocleavage reactions are present in the MALDI spectra.  This is due to 
UV pulse laser irradiation required for MALDI-TOF and has been observed previously 
when characterizing light-activatable oligonucleotides[4].   
c. Oligonucleotide ligation 
Purified oligonucleotides were ligated using Circligase II (Epicentre).  Briefly, 40 
pmol of oligonucleotide was reacted in a total reaction volume of 20 µL according to 
manufacturer’s recommendations.  The reaction was performed at 60 °C for one hour.  
Then, the enzyme was heat inactivated, and the reaction mixture was treated with 
exonucleases I and III (NEB, following manufacturer’s protocols) to cleave any 
oligonucleotide that was not circularized.  For oligonucleotide purification, the reaction 
mixture was extracted with phenol/chloroform and precipitated with sodium acetate.  
Finally, the circularized oligonucleotide was applied to an Amicon 10,000 Da molecular 
weight cut-off centrifugal filter unit to ensure the full-length oligonucleotide was isolated 
from any short, linear nucleotides produced during the exonuclease reaction.   
d. Polyacrylamide gel electrophoresis analysis of caged siRNA 
Samples (40 pmol of unligated caged siRNA, 40 pmol of caged siRNA after 
Circligase reaction, 20 pmol of purified caged siRNA after Circligase and exonuclease 
reactions, and 20 pmol of purified product after irradiation at 365 nm for 15 minutes) 
were brought to a total volume of 10 µL.  Then, 10 µL of loading buffer II (Ambion) was 
added to each sample, and they were loaded onto 20% polyacrylamide, 7 M urea gel.  
The gel was electrophoresed at 300 V for 45 minutes, and staining was performed with 
ethidium bromide for 10 minutes.  Gels were imaged on a Bio-Rad Gel Doc 2000 system.  
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Samples that were uncaged were irradiated with a UV transilluminator (Spectronics 
Corporation TL-365R) at 365 nm (9 mW/cm2 at peak intensity) for 15 minutes. 
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Figure S1.1   Caged siRNA structure and general ligation scheme.  2′-F bases are 
indicated in blue, DNA bases are black, and photocleavable spacer groups are red.  
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Figure S1.2  MALDI-TOF analysis of caged siRNA.  The peak at 14,310 corresponds to 
the intact caged siRNA (expected mass is 14,136).  The lower mass peaks are indicative 
of photolysis products resulting from oligonucleotide cleavage due to MALDI laser 
exposure.   
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Figure S1.3  Denaturing PAGE (20%) analysis confirming formation of circularized 
siRNA by ligation.  40 pmol of (1) unligated caged siRNA and (2) caged siRNA after 
Circligase reaction were loaded on gel.  20 pmol of (3) purified caged siRNA after 
Circligase and exonuclease reactions and (4) purified product after irradiation at 365 nm 
for 15 minutes were loaded on the gel.  The gel was electrophoresed at 300 V for 45 
minutes, and staining was performed with ethidium bromide for 10 minutes.  
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